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ABSTRACT 
Transportation is one of the most common production practices for cattle 
throughout the United States and the world. During this event, cattle handling, a new 
environment, and other compiled life events cause stress. Transport and stress influence 
inflammation, immune function and subsequently can lead to bovine respiratory disease. 
This disease complex is one of the largest production losses that the beef industry deals 
with on a daily basis.  In this dissertation, we tested the efficacy of a non-conventional 
therapeutic, meloxicam, to mitigate the negative response of transportation. The 
encompassed chapters hypothesized meloxicam given orally prior to transportation would 
reduce stress, reduce acute phase protein inflammation, reduce immune system 
inhibition, improve production performance benefits and improve clinical outcomes of 
disease. In the first trial, meloxicam was administered per os prior to a long-distance 
transportation at 1mg/kg. The study demonstrated a reduction in the stress leukogram and 
an inverse relationship of meloxicam to circulating cortisol in beef steers. In the second 
study, we compared the adaptive immune function invitro through multiparameter flow 
cytometry. Subjects were grouped in non-transport or transportation groups. Nested in 
these groups the subjects were treated with meloxicam or placebo. Meloxicam and 
transportation had an effect on adaptive immune function. Meloxicam administered prior 
to transport can be interpreted as inhibitory or homeostatic when compared to the 
singular effect of transportation on the immune system. Finally, the last phase of research 
was a clinical field trial to elucidate clinical outcomes of bovine respiratory disease. 
Three treatment groups of pre-transportation meloxicam, on arrival meloxicam and 
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placebo were compared.  Meloxicam had no effect on clinical outcomes of BRD. In 
addition, there was no change in the process of disease severity or rectal temperature at 
BRD identification. In similarity, there was no change in average daily gain, feed 
conversion or body weight performance measured at 42 days. The lack of significant 
differences over the course of the initial receiving culminated in no observable 
differences of harvest parameters. The dissertation research confirms that meloxicam is 
beneficial when administered prior to transportation for reduction of the stress and 
potential normalization of immune function but lacks clinical efficacy in mitigation of 
disease outcomes that translate to beneficial performance and harvest outcomes. 
1  
 
CHAPTER 1.  
GENERAL INTRODUCTION 
 
Dissertation Organization 
 The present dissertation is organized into 6 chapters focusing on cattle 
transportation and a novel therapeutic intervention; meloxicam. This first chapter is an 
outline of the dissertation that will be presented in the remaining chapters. Things of 
relevance in this chapter are the justification for investigation and the guiding hypothesis 
of each chapter. The second chapter is a literature review of cattle transportation designed 
for publication. The review is focused on the circulating biomarkers in cattle that have 
been monitored prior to and after transportation. In addition, the review highlights other 
non-antimicrobial therapeutics that have been used before or after transport in cattle. 
Circulating biomarkers of interest are related to behavior, stress, immune function, and 
acute phase proteins. The third chapter of the doctoral thesis is a research publication 
focusing on the effects of meloxicam (PO) on circulating physiologic biomarkers in beef 
steers after long distance transportation. The fourth chapter is the second research 
publication of my doctoral project. This project utilized flow cytometry to investigate the 
effects of transport and meloxicam (PO) on adaptive immunity.  The fifth chapter of my 
doctoral program is a clinical trial formatted for publication and focused on feed yard 
clinical outcomes. The trial outcomes of interest consisted of; monitoring for signs of 
BRD using the DART system and examining live performance weight and carcass 
characteristics at harvest. The comparison of this study focuses on oral administration of 
meloxicam prior to transportation, meloxicam on arrival and inactive excipient placebo 
groups. The final; sixth chapter of the thesis dissertation presents the summary and 
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conclusions that can be drawn from the research conducted in this dissertation as well as 
the guidance for future research. 
The coauthors listed on the submitted manuscripts had contributions to research as 
described below: Johann Coetzee was my major professor and was involved on all fronts 
of research such as study design, manuscript feedback, data collection, and analysis. 
Matthew Stock and Locke Karriker were instrumental in the aid of data collection and 
manuscript revisions. Procurement of cattle for research would not have been possible 
without the guidance and support of Terry Engelken, Rhonda Vann, Caleb Lockard, Clint 
Krehbiel and Blake Wilson. Darrel Busby managed cattle over the feeding period. Larry 
Wulf was instrumental in teaching the chemistry involved for drug extraction and 
quantification. Walter Hsu was a mentor through the methods and process of RIA. Jeff 
Lakritz was critical in quantifying Hp-MMP9 through ELISA. Andrew Carpenter and 
Barry Bradford where critical at quantifying TNF alpha in their specialized in-house 
ELISA. Chong Wang and Natalia Cernicchiaro contributed additional insight and 
validation of my own statistical findings. James Roth and Ratree Platt were integral in the 
development of the flow cytometry method, and execution of the flow cytometry. Erin 
Kalkwarf performed the BVDV antibody titer VN assay in the Iowa State Diagnostic 
Lab. Data for additional biomarker quantification through annexin A1 quantified by Jeff 
Caswell.   
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Relevance of NSAIDS as a Justified Therapeutic Administered Prior to 
Transportation for the Reduction of Pain and Inflammation in an Effort to Mitigate 
Bovine Respiratory Disease.  
The nonintegrated nature of the beef system as well as the spatially fixed elements of 
infrastructure in specific economic, geographic, and environmental conditions requires 
almost all beef cattle to encounter a transportation event at some point in their life time 
(Gorsich et al. 2016). Economic loss associated with transportation is closely associated 
with disease outcomes. Commonly “shipping fever” or fibrinous pneumonia due to 
Mannheimia haemolytica as well as other respiratory pathogens have been suggested to 
cost the feedlot industry an average of 7 % of total production costs (Griffin 1997). BRD 
associated inflammation increases the overall production costs and adds to the upfront 
antimicrobial cost (Gifford et al. 2012). More recent surveys from the national health 
monitoring system has seen a two fold increase in price to treat respiratory disease since 
1999 without a decline in BRD incidence  (NAHMS 2013). Summaries for cattle 
harvested in 2015 year, according to the USDA Livestock Slaughter, reached upwards of 
30 million head and accounting for total losses near 1 billion dollars annually.  
Transportation effects on cattle have been evaluated extensively in multiple settings 
and modalities across the world. Livestock are subject to transport by road, railcar and 
ship (Phillips and Santurtun 2013, Ashby et al. 1979, Schwartzkopf-Genswein and 
Grandin 2014). Each transport experience has been suggested to have associated 
detrimental aspects, however they vary in severity. Transportation in the United States 
involves animal handling, comingling, weight loss and stress (Broom 2007). Cattle 
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appear to recover uneventfully from the transportation event within 24- 48 hours of rest 
(Earley, Drennan and O'Riordan 2013). However, calves are at a higher risk to develop 
respiratory disease. Disease pathogenesis is a multifactorial process that ultimately results 
from impairment of the innate and adaptive immune responses (Caswell 2014). The 
impairment can be detected in circulating physiologic parameters associated with 
metabolism, the endocrine system, and the innate and adaptive immune system (Marques 
et al. 2012, Fike and Spire 2006, Bernardini et al. 2012). Variations in responses have 
been characterized with differences in sex, breed, age and length of the transportation 
events. These have been used to understand the underlying process that contributes to the 
stressful nature of transport predisposing cattle to disease responses with limited success.  
Current practices for controlling BRD in cattle involve the use of antimicrobial 
metaphylaxis to combat the anticipated morbidity over the feeding period (Ives and 
Richeson 2015, Vandonkergoed 1992). The advent of niche marketing and consumer 
demand have opened marketing channels for cattle never treated with antimicrobial 
agents (Fox et al. 2008). With this rising consumer demand and a potential regulatory 
future eliminating antimicrobials as seen in the European union, other therapeutics for 
disease reduction or performance enhancement warrant investigation (Lean 2013). This 
potential shift leaves a void in the veterinary medical profession for research into novel 
prophylactic treatments for transportation detriments. Previous work has shown benefit 
with the use of non-steroidal anti-inflammatory drugs (NSAIDs) after transportation in 
the face of veterinary practices known to increase BRD, such as arrival castration 
(Coetzee et al. 2012a). The inflammatory and stress response associated with 
transportation is a primary source of problems for incoming calves. In addition NSAIDs 
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have been studied as a means for analgesic relief resulting in mitigation of the stress 
response in cattle (Coetzee et al. 2012b) and have been shown to reduce lung lesions 
(Lockwood, Johnson and Katz 2003).  
There is no approved therapeutic that is labeled for pain or stress relief in cattle 
undergoing transportation. Veterinary approval for the use of meloxicam falls under the 
animal medicinal drug use clarification act (AMDUCA) of 1994 as extra label drug use 
(ELDU). Guidance for ELDU requires that drug use be under the guidance of a 
veterinarian, with approved animal and human drugs, when the health of the animal is 
threatened, and not for production purposes. In addition, these drugs may not be used in 
feed and a violative residue is prohibited. Meloxicam is a NSAID that is a member of the 
oxicam class and selectively but not preferentially prefers COX II inhibition (Plumb 
2015). Kinetically meloxicam has been investigated to have a longer half-life than the 
only approved NSAID for treatment of pyrexia in cattle, flunixin meglumine (Coetzee et 
al. 2015). Currently meloxicam is approved for use in the European Union and Canada as 
follows: as an adjunct therapy for BRD, diarrhea, mastitis and the pain alleviation for calf 
disbudding (EMA 2016). Uses in cattle during veterinary procedures, such as castration 
have reduced disease outcomes in treated animals (Coetzee et al. 2012a). Due to the 
aforementioned information, we develop a hypothesis for candidate drug investigation as 
a therapeutic to impact beef steers undergoing long distance transportation.  
Guiding Hypothesis for the Dissertation 
 The hypothesis of the first research project in the dissertation was the investigation of 
meloxicam (15 mg / tablet) delivered orally at 1 mg / kg prior to long distance 
transportation would reduce the inflammation and stress associated with transportation. 
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Previous literature implemented an efficacious dose at 1mg/kg in cattle (Coetzee et al. 
2012a). We analyzed hematology and plasma parameters to confirm these outcomes. 
Hematology consisted of a CBC prior to transport, on arrival and six days later. Cortisol, 
cytokines and acute phase proteins were also analyzed at these timepoints. Meloxicam 
treatment reduced the stress leukogram. Drug concentration was inversely proportional to 
cortisol, neutrophils, and basophils. Our results allowed us to accept this hypothesis and 
further target investigation of meloxicam usage during long distance transportation. As a 
result of chapter three’s findings, we attributed the treatment effects of meloxicam 
required investigation of four specific aims for this dissertation: (1) stress and 
inflammation, (2) changes in immune function, (3) reduction in respiratory disease, (4) 
decreased disease translating to increased animal performance. 
 The fourth chapter study design evaluates the effects of meloxicam and 
transportation on the adaptive immune system through humoral and cell mediated 
responses. The null hypothesis was applied. Meloxicam administration prior to 
transportation would have no effect on immune system function compared to control 
groups. The second alternative hypothesis was directed at transport effects, suggesting 
that stress would be deleterious to immune function decreasing the CMI. Immune 
function was tested with a booster vaccination on arrival to evaluate cellular responses 
seven days after arrival. The cell mediated immune response of PBMC’s stimulated with 
BVDV antigen was quantified in vitro through flow cytometry (Platt et al. 2009). The 
humoral response was evaluated through antibody quantification in VN assay conducted 
at the Iowa State University Veterinary Diagnostic Lab. The study findings allowed 
rejection of the null hypothesis. This project demonstrated the drug treatment of 
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meloxicam was either homeostatic or inhibitory on the adaptive immune system day 7 
post arrival vaccination. In addition, transportation was non-inhibitory on adaptive 
immune function at arrival and seven days after the on-arrival booster vaccination. This 
data allowed us to reject the alternative hypothesis. Though the third and fourth chapters 
gave valuable insight into the goals of the first two specific aims, there was still a 
necessary research culmination required to complete the third and fourth aims of the 
dissertation.   
 As a result of in vitro evaluation for inflammation and immune response after 
transportation, the fifth chapter is focused on the alternative hypothesis that meloxicam 
has stress reducing, homeostatic immune modulating benefits to reduce disease with in 
the first forty-two days of the feeding period. Due to the anti-inflammatory and analgesic 
properties of the NSAID, a secondary alternative hypothesis postulated that meloxicam 
treated steers would have increased weight gain and feed conversion over the first forty-
two days. After multiple dialogues with producers and practicing veterinarians an 
additional arm was added to the study design in the sixth chapter. A treatment group of 
meloxicam administration on arrival was added to compare effects to the meloxicam 
administration prior to transportation and control animals. We rejected our hypotheses. 
There was no main effect of therapeutic meloxicam treatment on reduction of disease. 
Weight gain and feed conversion were also unaffected by treatment.  Within the same 
study design the subjects utilized in chapter 5 were also used to evaluate treatment effects 
on carcass at the end of the feeding period. The original idea of an increased health 
benefit with in the first forty-two days would translate to carcass merit differences at 
harvest. No differences at harvest were seen between either meloxicam treated groups 
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and the control animals. Due to the lack of significant findings performance data was 
incorporated into the fifth chapter rather than becoming a standalone chapter.  
 Collectively, these studies suggest a benefit of meloxicam’s use biologically with 
in the first week of the feeding period. The benefits include a reduction in the stress 
response of transportation. Other effects on immune function have implications but were 
not translated to disease. We confirmed the stressful nature of transportation on cattle that 
are shipped for long distances. In addition, the stressful nature of transport is more 
detrimental from a disease perspective on calves that are smaller in body weight. 
However, the justification for use to indirectly mitigate disease using a non-steroidal anti-
inflammatory has been proven ineffective. As a standalone treatment meloxicam is not 
beneficial as a prophylactic transportation treatment to reduce bovine respiratory disease, 
further research is warranted to evaluate the modality of combinatorial or successive 
treatments after arrival for the reduction of disease in the feed yard. The remaining 
chapters highlight the process and research that substantiate this finding.  
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CHAPTER 2. 
THE MULTIFACETED EFFECTS OF TRANSPORTATION ON CATTLE 
PHYSIOLOGIC PARAMETERS; A REVIEW  
 
Modified from a manuscript submitted to Animal Health Research Reviews 
 
N.K. Van Engen,* J.F. Coetzee† 
 
Abstract (300 words) 
The goal of this review is to present a concise and critical assessment of the literature 
related to physiologic responses in cattle that are subjected to transportation. Over two-
thirds of United States cattle are transported. Understanding trends in circulating 
physiologic parameters is an important part of mitigating negative effects of 
transportation. For the producer, linking these effects after transportation to morbidity 
outcomes within the first 45 days on feed (i.e., especially development of bovine 
respiratory disease) is critical. Physiologic parameters in circulation are of primary 
importance and may have value for prediction of bovine respiratory disease (BRD) on 
arrival and for understanding of disease pathogenesis. The results of our literature survey 
indicated that post-transportation immune function, increased acute phase proteins, 
glucocorticoids, and inflammation are a pivotal starting point for understanding disease. 
                                               
* Veterinary Microbiology, Iowa State University  
† Anatomy and Physiology, Kansas State University 
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These potential biomarkers may have utility in identifying disease for targeted 
therapeutics so that traditional protocols that rely heavily on metaphylaxis can be 
avoided. Additional research is needed to develop strategies for physiological marker 
identification, treatment methods, or predictive behaviors to prevent respiratory disease 
before and after transport. This review examines the significant deleterious effects of 
transportation handling and stress, and current immune system translation and non-
antimicrobial mitigation strategies. 
Keywords: transport, cattle, stress, immune system, acute phase proteins 
 
Introduction  
Transportation of cattle is a management intervention that can occur during 
significant bovine life events including sorting, weaning, processing, and slaughter 
(Schwartzkopf-Genswein and Grandin, 2014, Swanson and J., 2001). Transportation is a 
stressor that predisposes calves to the development of bovine respiratory disease (BRD). 
At least 7% of the cost of cattle production can be attributed to BRD (Griffin, 1997). The 
financial costs associated with BRD-induced shipping fever are extremely high. The 
United States Department of Agriculture estimates that the cattle industry loses 1 billion 
USD each year from shipping-associated BRD. Most of the approaches to respiratory 
disease management in cattle are limited to vaccination and antibiotics to decrease 
disease prevalence and severity (Penny, 2015). The physiological changes that occur 
during transportation begin with dehydration (Galyean et al., 1981), lack of feed intake 
(Cole et al., 1988, Galyean et al., 1981), tissue damage (Murata et al., 2004), fume 
inhalation (Wong et al., 2004, Wong et al., 2003), and physical and psychological stress. 
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These changes can result in immune system inhibition from prolonged exposure to 
stressful stimuli. Inflammation due to cytokine and acute phase protein responses are 
consistent components of BRD progression. Inflammation from BRD within the lung 
significantly affects performance through decreases in daily gain, dry matter intake, and 
feed conversion (Gifford et al., 2012). The additional increases in inflammation can result 
in increased pyrexia- and cachexia-related energy demand, which leads to protein 
resorption from skeletal muscle. 
  
Though there is evidence for decreased immune function and increased 
inflammation, little intervention is performed in cattle prior to transportation (Duff and 
Galyean, 2007). Most, if not all, of conventional on-arrival metaphylaxis or vaccination, 
or both, occurs within the first weeks after arrival (White et al., 2015, Richeson et al., 
2006). A recent diagnostic laboratory investigation revealed that during the 3-year period 
from 2009–2011, the prevalence of antimicrobial resistance in submitted isolates of 
Mannheimia haemolytica increased from 5% to 35% (Lubbers and Hanzlicek, 2013). 
Consumer concern about resistance in meat products resulted in the development of 
organic and all natural product niche markets (Sofos, 2008). Though development of 
resistance has been documented in respiratory pathogens after antimicrobial treatment, 
changes in common foodborne pathogens have not been consistently found to be different 
(Fox et al., 2008). Valid methods that can be used to identify the cattle most susceptible 
to disease while in the feed yard are needed. Some early detection behavior methods have 
been proposed to remotely detect cattle that are displaying typical behaviors that indicate 
the presence of respiratory disease, without the need for human interaction (White et al., 
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2015). Previous research studies have also examined the use of trends in physiologic and 
metabolic parameters after the cattle arrive at their destination. There is no single 
biomarker that indicates BRD risk upon arrival and no mitigation strategy has been found 
to be solely effective in decrease of BRD incidence. Compiling a trend of increasing and 
decreasing biomarkers may be the best possible method for indicating problematic groups 
of cattle, and the use of non-antimicrobial methods to help decrease BRD prevalence for 
incoming cattle requires investigation. For this review, relevant transportation effects on 
BRD risk are depicted in Figure 1; the figure illustrates the complex connections within 
the cascade of events that result in clinical respiratory disease.  
 
Deleterious Effects of Transportation 
At the cellular level, tissue damage results in release of the membrane 
phospholipid bilayer and incites an inflammatory cascade at the site of injury through the 
conversion of lipid membrane into prostaglandins and other metabolites (Enyedi et al., 
2016). During road transport, the truck environment and truck-associated parameters can 
have characteristics with an underlying predisposition to cause tissue damage, 
discomfort, and added stress. Environmental stressors such as climate, nutrition, and 
human intervention have critical roles in animal welfare (Bova et al., 2014). The truck 
design, stocking density, driver, road quality, and ventilation and ambient temperature of 
the hauling container are important factors to consider during an assessment of transport 
conditions (Broom, 2008). The pre-transport loading process can be the most stressful 
part of the trip, and the stress response then normalizes while the cattle are in transit 
(Pettiford et al., 2008). Loading stress can be associated with cattle that have high 
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temperaments or calm temperaments (Burdick et al., 2011). During loading or transit, 
movement of the cattle can increase the chances for soft tissue injury. Rough roads and 
improper handling can cause carcass bruising, which is detrimental to animal welfare and 
is an additional loss in product at the packer (Huertas et al., 2010). Damage that occurs 
when unloading large groups of cattle into a pen is located in the perianal and hip bone 
area of the carcass (Honkavaar et al., 2003). If the cattle are not destined for slaughter, 
the bruising nature of the shipment process can affect behavior. This trauma combined 
with the distance traveled may be associated with the animal’s responses to the 
transportation event. Compared with shorter distances, travel distances greater than 40 
miles from the slaughter house are associated with a statistically significant increase in 
bruising risk (Jarvis et al., 1996). However, bruising is inevitable regardless of the travel 
distance. The increases in bruising can be monitored physiologically using increases in 
plasma creatine kinase concentrations. One study found that increases in creatine kinase 
occurred in veal calves during transport, but there was no correlation with the amount of 
muscle bruising at harvest (Grigor et al., 2004).  
After arrival at the destination, normal cattle behavior is altered as cattle 
recuperate. Immediately after transport, heifers spend more time at the hay feeder; they 
also lay down more often 1 to 2 days after transport, compared with control heifers 
(Theurer et al., 2013). These findings are consistent with the loss of body weight in the 
form of rumen gastrointestinal contents and the physical exertion required to stand the 
entire transport period. A split 9-hour transport, 12-hour rest, and 9-hour transport study 
revealed that during the first and second 9 hours in transport, bulls spent significantly less 
time lying down compared with their non-transported counter parts; there were no 
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differences in lying or standing during the 12-hour rest period (Earley et al., 2013). 
Counterintuitively, non-transported bulls spent significantly more time in recumbency 
than bulls that were transported. Results from other observational studies have indicated 
that on arrival and following transport, young bulls spent less time acclimating or 
exploring the new home pen and more time interacting with each other (Cafazzo et al., 
2012). 
The transport truck’s compartment environments are not equal; there are 
compartment-associated differences in average daily gain and disease risk (White et al., 
2009). Cattle in the forward sections or transported in spaces with less than 15 head have 
reduced odds of treatment. Vibration of the vehicle while in motion can affect the 
animals during transportation. The greatest vibration occurs on gravel roads. When cattle 
assume a position perpendicular to the direction of travel, they experience significantly 
less vibration (Gebresenbet et al., 2011). Vibration originating predominantly from the 
vertical axis of the trailer is dependent on tire pressure (Stevens and Camp, 1979). Many 
truck design characteristics, and the road conditions that are traversed to move livestock 
from point “A” to point “B,” cannot be readily changed but there are parameters that 
should be controlled. The driver’s behavior during transport affects the cattle’s behavior 
(Cockram and Spence, 2012). Driver tendencies can be defined by the need to accelerate 
or brake in certain situations, but most are less frequent during highway transit. There is a 
lower probability of sudden changes during highway driving. The role of the driver in the 
prevention of animal discomfort is important and easy to address. 
Increased values for PCV and total protein concentrations are evidence of the 
dehydration that occurs during shipping (Jarvis et al., 1996). Dehydration is directly 
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related to disease due to the disruption in the mucociliary apparatus function of the 
respiratory epithelium (Ackermann et al., 2010). The ambient temperature in the 
transportation environment is a potential cause of dehydration. When the temperature is 
outside the animal’s normal critical limits, energy expenditure increases to maintain body 
temperature homeostasis. Most trailers that are hauling cattle depend on movement to 
provide ventilation; a stationary position results in stagnant conditions. Quantification of 
the trailer’s temperature climate is difficult to interpret when one temperature logger is 
used; multiple loggers should be used to obtain more accurate information (Goldhawk et 
al., 2014a). However, there are some management benefits from limited logger 
information. Time of year and ambient conditions are key inputs for decisions and 
associated risks during transport (Goldhawk et al., 2014b). In-transit temperatures >30°C 
have adverse effects on thermoregulation. Heifers shipped at high ambient temperature 
(>32°C ) had significant behavioral changes, weight loss, and peripheral 
vasoconstriction-associated nasal and rectal temperature decreases (Theurer et al., 2013).  
The most significant aspects of transport for consideration and avoidance are transporting 
unfit cattle and long-distance transportation without stops for food, water, and rest 
(Schwartzkopf-Genswein and Grandin, 2014). An unavoidable loss of bodyweight (i.e., 
shrink) occurs during transport. This effect usually occurs due to the lack of feed and 
water, and increased defecation and urination. Marques et al. found that food deprivation 
in transport is the major factor that accounts for lost performance (Marques et al., 2012). 
They transported bulls for 24 hours and allowed one period of rest at 12 hours with no 
access to food or water. The animals had statistically significant decreases in body 
weight, compared with control animals who were rested and received rations. The 
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decreased performance in this study was identical between groups of animals fasted for 
24 hours, despite transportation effects. The effectiveness of a rest stop with access to 
food and water for avoiding the performance losses during transport was examined by 
(Cooke et al., 2013b). The results for use of a 2-hour rest stop at the half-way point of a 
1,290-km journey with ad libitum hay and water access were not different from the 
results for straight-through transport. Only the non-transported control animals had 
greater feed to gain and average daily gain values. Even when transporting young calves 
for a duration of 19 hours, there is no benefit from a 1-hour feeding stop (Knowles et al., 
1999). This finding is supported by other results that calves regain their original body 
weight by 24 to 72 hours post-transport (Knowles et al., 1997). The losses occur during a 
wide time interval. Most of the gut contents are lost during first 24 hours of transport, but 
the greatest rate of loss occurs within the first 12 hours (Knowles, 1999). 
Shrink is a measure of performance, but it is also associated with the health of 
cattle that are transported. Loss of bodyweight in lighter weight cattle may be connected 
to increased morbidity and mortality, but increased hot carcass weight and average daily 
gain during the post-transport period (Cernicchiaro et al., 2012b). For the body weight 
loss variable, there were similar outcomes for morbidity, mortality, hot carcass weight, 
and average daily gain when distances traveled were compared (Cernicchiaro et al., 
2012a). However, as the distance increased the likelihood of a negative effect health 
outcomes also increased. Cernicchiaro et al. found that procurement of cattle from 
specific regions of the United States correlated with increased post-transport morbidity. 
Other study findings indicated there were no correlations between the shrink that results 
from short- or long-term transportation and the development of respiratory disease 
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(Ribble et al., 1995b). Ribble et al. found a strong correlation between comingling calves 
from different sources and subsequent development of BRD (Ribble et al., 1995a). These 
conflicting results indicate the multifactorial nature of the BRD process. However, it is 
highly likely that comingling, arrival weights, and shrink are associated with disease risk. 
During the transportation process cattle are exposed to potentially irritating diesel 
fumes. Fumes can consist of organic compounds (e.g., aldehydes, benzenes, and 
polycyclic aromatic carbons) that are disruptive to the mucosal epithelium (Wierzbicka et 
al., 2014). Wong et al. found that exposure of rats to diesel exhaust can cause neurogenic 
pulmonary responses that can perpetuate lung inflammation (Wong et al., 2003). Diesel 
fume disturbance and disruption of the respiratory mucosal system can be a large 
contributor to respiratory impairment and subsequent disease (Riedl and Diaz-Sanchez, 
2005). Other heavy metals (e.g., vanadium) that are released during exhaust excretion of 
diesel fuels cause inhibition of the innate defenses of the respiratory epithelium (Klein-
Patel et al., 2006). Fumes and their effects on respiratory disease are difficult to study in 
cattle and are best interpreted through extrapolation of research findings from other 
mammalian species.    
Biomarkers of Stress  
Components of the bovine endocrine system and non-endocrine physiological 
parameters have been used to quantify the level of stress.(Arthington et al., 2003) Neural-
hormonal biomarkers of interest have been identified (i.e., ACTH, cortisol, 
catecholamines, and iodothyronines). The rapid release and degradation of these 
hormones and the natural, circadian rhythm release during the day present a challenge to 
the use of these markers for biological assay (VanCauter et al., 1996).  
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  Glucocorticoids (specifically cortisol) are released during stressful situations, but 
responses are delayed due to transcriptional downstream effects from cytoplasmic 
receptor complexes that interact with DNA. Glucocorticoid interference can inhibit 
signaling mechanisms (e.g., TLR-4) during dendritic cell maturation; these signaling 
mechanisms are critical for the innate defense response and lipopolysaccharide 
recognition (Rozkova et al., 2006). Other DNA transcription effects increase during 
glucocorticoid upregulation of the gluconeogenic capacity of the liver to use amino acids 
and fatty acid mobilization for energy creation (J.E., 2006). In addition to metabolic 
functions, cortisol has inhibitory effects on inflammation, vascular permeability to white 
cells, and the immune system (i.e., primarily for lymphocyte reproduction) (J.E., 2006). 
Although not studied extensively in cattle, the effects of circadian rhythms are important 
for the interpretation of cortisol levels over periods of time; there are variations in normo-
physiologic secretions throughout the day (VanCauter et al., 1996). 
The hypothalamus pituitary adrenal (HPA) axis should be considered during 
investigation of transportation effects on cattle. Sustained stressor events result primarily 
in corticosteroid and aldosterone release (vonBorell, 2001). Cortisol is the main 
corticosteroid measured in studies of the stress response (Table 1). Cortisol can be used 
as a biomarker that is linked with behavior responses in cattle; anxiety is indicated by less 
time ruminating and increased vocalization (Bristow and Holmes, 2007). Cortisol 
identification methods include measurement in plasma, hair, and the fecal contents of 
calves during transport (Marti et al., 2017, Mostl et al., 2002, Arthington et al., 2003). 
Results for beef bulls indicated that 4.5 hours after the start of a 9-hr transportation event 
there was a 321% increase in cortisol concentrations, compared with a 24-hr baseline 
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sample that was taken before transportation began (Buckham Sporer et al., 2008). Other 
groups and reviews confirm that the cortisol increase that occurs during transportation 
can be used as a marker of stress (Odore et al., 2011, Knowles, 1999, Gupta et al., 2007). 
Ruling out a novel environment as a cause of stress is important. Arrival at an original 
starting point location versus a naïve arrival location had minimal effects on cortisol 
levels (Browning and Leite-Browning, 2013). 
 Effects revealed after longer transport distances can potentially cause a decrease 
in the cortisol response that may be due to the extensive fasting or exhaustion associated 
with the journey (Van Engen et al., 2014). Supporting results indicated that increased 
transport time correlated with a decrease in the level of plasma cortisol concentration 
(Bulitta et al., 2015, Gebresenbet et al., 2012). This change could be caused by the 
animal’s acclimation to transport. However, attributing the cortisol response only to 
transportation-related variables excludes other variables associated with the cortisol 
response. Cattle handling and processing variables may also contribute to the stress 
response. In addition to animal handling, the effects of the individual animal’s 
temperament should be considered when cortisol is examined (Burdick et al., 2010). 
Regardless of differences in animal handling style, temperament can confound the 
outcome. Conclusions have greater validity when temperament is not a factor.  
 
Counterintuitively with the HPA axis, corticotropin releasing hormone can have 
alternate effects from cortisol. Corticotropin releasing hormone increases the 
inflammatory response of macrophages in vitro and incites increased production of 
inflammatory cytokines (Agelaki et al., 2002). ACTH did not increase prostaglandin 
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levels in pregnant cows (Geary, 2012). This result suggested that specific pathways of 
inflammation can be affected by physiologic fluctuations in CRH, ACTH, and cortisol. 
Regardless of circulating cortisol levels in response to stressors, it is important to note 
that there is a complex relationship between glucocorticoid synthesis and development of 
BRD (Senthilkumaran et al., 2013). Annexin A1 is a protein found in epithelial 
secretions. Concentrations of annexin A1 correlate with circulating cortisol 
concentrations. However, calves that do not develop BRD while in the feed yard have 
increased Annexin A1 concentrations, compared with calves that do develop BRD 
(Senthilkumaran et al., 2013). This finding emphasizes the complex associations between 
glucocorticoids, stress, and BRD.  
A short startle response induces the hypothalamic adrenal medullary system (i.e., 
the fight or flight response) and causes increased sympathetic tone. Similar to cortisol, 
epinephrine and norepinephrine responses are correlated with animal temperament (Table 
1). Compared with calm bulls, temperamental bulls have elevated epinephrine levels 
following transportation (Burdick et al., 2010). Two studies found that transportation 
alone increased norepinephrine (Odore et al., 2004) and epinephrine (Odore et al., 2004, 
Aktas et al., 2011), but temperament was not included in the analyses of the results of 
either of these studies. The short half-lives of epinephrine and of norepinephrine within 
the biological system negatively affects the value of these parameters as biomarkers for 
the identification of stress. 
Tri-iodothyronine (T3) has many and diverse functions in tissues; T3 is a 
metabolically important hormone. The effects of periods of stress due to handling and 
transport on changes in T3 levels have been investigated. The results indicated that there 
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was an increase in T3 concentrations after transport and after handling events, but there 
were no differences between the post-transport and post-handling T3 concentrations 
(Mitchell et al., 1988). Mitchell et. al (1988) suggested that the transport effect was 
confounded by the need to handle the animals after transport and that the effect of 
handling, not transport, was the cause of the T3 increase. Further research on post-
transport T3 levels is needed, but one plausible hypothesis is that increased metabolism 
mobilizes nutrients during the fasting that occurs during transport.  
Cortisol and catecholamines control metabolism in the liver and are included in 
pathways important for processing carbohydrates (gluconeogenesis), proteins, and lipids 
(lipolysis) (Gifford et al.). Investigations of specific hematological outcomes associated 
with circulating energy modifications are of interest because of the shrink and fasting 
effects of transport. Non-esterified fatty acids, glucose, and albumin levels in blood were 
elevated, and beta-hydroxybutyrate levels in blood were decreased, after transport (Earley 
and O'Riordan, 2006, Cafazzo et al., 2012, Earley et al., 2010). Other results indicate 
there is an increase in beta-hydroxybutyrate following transportation, which is relevant to 
a metabolic fasting state (Bernardini et al., 2012). Increases in these elements of a blood 
panel are consistent with the effects of cortisol during the stress response. Breed 
differences in cortisol response between a group of Brahman steers and a group of 
Hereford steers may account for the significant glucose increase in the Brahman, 
compared with the Hereford, group (Browning and Leite-Browning, 2013). Although 
glucose increases, the return to homeostasis occurs within 24 hours of the transport event 
(Earley et al., 2010). Lipid mobilization also occurs during the shrink and fasting states of 
transportation. Mobilization is linked with increased non-esterified fatty acid levels in 
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circulating blood after transportation (Cooke et al., 2013a). Non-esterified fatty acid 
increases are linked to catecholamine release (Agnes et al., 1990). A reduction in non-
esterified fatty acid metabolism occurred in cattle transported for 1,290 km when there 
were two, 2-hour stops with feed and water (i.e., at each 430 km). However, this 
intervention reduced but did not eliminate the increase in the non-esterified fatty acid 
response (Cooke et al., 2013b).  
Metabolic markers can be used for more than indicators of fasting. Lactate 
concentrations can be significantly elevated after transport and correlated with transport 
time (Chacon et al., 2005, Bulitta et al., 2015). Lactate is a marker for transport-
associated muscle fatigue; longer distances and increased standing times can cause 
increased lactic acid production due to oxygen depletion and the inability to re-
phosphorylate ADP (Sahlin, 1986). The circulating blood level of creatine kinase has also 
been studied as a marker of muscle damage. Most investigators have found elevated 
creatine kinase levels upon arrival (Bernardini et al., 2012, Earley et al., 2010, Grigor et 
al., 2004, Van de Water et al., 2003). However, the results of another study indicated that 
there were no significant changes in creatine kinase following transport (Cafazzo et al., 
2012). Increases in creatine kinase can be used as an indicator for exertion associated 
with transport. However, fluctuations in creatine kinase levels do not always result in 
significant effects and can vary based on trip- and animal-associated differences. 
  Results from a castration trial indicated that the neuropeptide substance P (i.e., a 
derivative of the nociception response) can be used as a biomarker (Coetzee et al., 2008). 
Other implications of the peptide in physiology include effects on mast cell degranulation 
and migration of macrophages to the lung epithelium during acute respiratory infection 
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(Ramirez-Romero et al., 2001). Substance P has been examined during transportation 
events. Increases have been documented on arrival and at 4 hours after arrival, compared 
with baseline levels (Theurer et al., 2013), and at 24 hours post initiation of transportation 
(Van Engen et al., 2014). Discovery and expansion of the pain biomarker library in cattle 
is crucial for understanding of welfare issues.  
Immune System Translation  
Increased stress and glucocorticoid release engenders the loss of a host’s ability to 
prevent BRD. The immune system should be included in an examination of ways to 
prevent disease and potential pathways of pathogenesis. 
  Stress and inflammatory responses can mediate immune system signaling through 
changes in the peripheral blood cellular profile.  Transportation is accountable for a 
stress-induced neutrophilia (Earley et al., 2006, Earley and O'Riordan, 2006). There are 
two different understandings of neutrophil functionality after transportation. Indications 
have been made for a reduction of neutrophil oxidoreductase activity at arrival and 
increases four hours after arrival (Murata et al., 1987). Others report reductions in 
phagocytic neutrophil intensity at 48 h post-transit (Burdick et al., 2011). Linking these 
changes has been investigated at an expression level. The increasing circulating 
neutrophil genetic expression level suggests an increase in antibacterial function. 
Neutrophilia upregulation and the corresponding bacteria killing properties occur through 
increases in tissue remodeling matrix metalloproteinase 9, and decreased expression of 
the apoptotic marker FAS and extravasation cell marker L selectin. (Buckham Sporer et 
al., 2008). Neutrophil phagocytosis and oxidative burst capacity increase, and beta 2 
integrin essential for extravasation out of the vasculature decreases, after transport 
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(Hulbert et al., 2011). Transport leads to neutrophils that are activated in circulation but 
with a diminished ability to enter tissue, and a neutrophilia occurs. Hulbert and 
colleagues also found that upregulation of phagocytosis creates resistance to a microbial 
threat in calm-disposition cattle compared with temperamental cattle. The numbers of 
neutrophils expressing a betaglycan gene correlated with decreased lung lesions and 
pulmonary adhesion, when the gene expression was elevated 7 days after transportation 
(Eitam et al., 2010). However, the increased betaglycan results were not statistically 
significant following a 9-hour transportation (Buckham Sporer et al., 2007). Betaglycan 
is of primary interest because it binds to TGFβ. TGFβ is involved in the development of 
lung pathology that results in fibrosis of lung parenchyma (Bartram and Speer, 2004). 
Betaglycan has potential as a genetic marker for BRD in calves that are arriving in the 
feed yard. Betaglycan measurement may be a tool that can be used to identify calves that 
would eventually succumb to the effects of chronic lung fibrosis.  
Lymphocytes are the main adaptive immune functioning cells in the bovine. 
Transportation events are associated with decreases in the numbers of peripheral 
circulating lymphocytes (Earley and O'Riordan, 2006). These events have also been 
associated with decreased lymphocyte blastogenesis (Murata, 1989) and function (Murata 
and Hirose, 1991). Despite decreasing lymphocyte counts after transport, the level of 
circulation natural killer cells is positively correlated with the increasing post-transport 
levels of cortisol (Ishizaki and Kariya, 2010). A decrease in the ratio of lymphocytes to 
granulocytes is accounted for by an increase in circulating granulocytes (Kang et al., 
2017). Post-transport lymphocyte changes in expression cause significant upregulation of 
the heat shock proteins 70A1A and 60, which has a cytoprotective effect (Eitam et al., 
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2010). Lymphocytes were taken from transported Holstein-Friesian bulls, cultured, and 
stimulated with concanavalin A; the decrease in IFNγ production suggested there was a 
decrease in immune function (Gupta et al., 2007). Other findings have suggested that 
IFNγ is not inhibited in specific T cell populations upon stimulation; in some cases it is 
enhanced by transportation when cells are stimulated in vitro (Van Engen et al., 2016). In 
transported pregnant dairy heifers, the change in the different populations of lymphocytes 
has been described as a shift to CD 8+ cells (Kang et al., 2017). Deciphering the age-
related changes in T cell populations is critical when considering susceptibility to BRD 
complex because most of the circulating population in young calves consists of γδ T 
cells. 
Most of the literature describing adaptive immunity in cattle following 
transportation discusses the humoral response. Polyclonal antibody concentrations 
increase within the first 15 days after a transport event (Razzuoli et al., 2016). This result 
suggests that calves can have an immunological response after a transportation event. 
Calves naïve to keyhole limpet hemocyanin were vaccinated against the antigen to 
determine the differences in immune responses between transport and non-transport 
animals for several antibody classes. After 10 days, transported calves had significant 
increases in IgG1 through a weaning*transport interaction. At 20 days, IgG1 was 
increased in the transport group compared with the not transported calves. However, 
there were no changes in IgA or IgM on either of those days (MacKenzie et al., 1997). 
Different vaccination choices (e.g., use of a modified live virus vaccine) can change the 
outcome of a calf’s immune system responses, depending on age at vaccination 
(Richeson et al.). Conversion of an antibody response indicated that was a higher BVDV 
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type 1 antibody titer at 14 days compared with delay vaccinates, without a compromise in 
performance during a 56-day receiving period (Richeson et al., 2009). Vaccination within 
the receiving period results in variability in performance outcomes, and positive and 
negative effects. The result of a comparison between cell mediated immunity on arrival 
and at 7 days after use of an on-arrival vaccination also supports the hypothesis of a 
maintained immune function response (Van Engen et al., 2016). The results suggest that 
transport does not have a substantial prolonged effect on a parenterally induced immune 
response. Immune function impairment associated with shipping stress could be confined 
to the lung and increases the likelihood of shipping fever. In contrast., stress is a result of 
prolonged and multifactorial events and transport alone is not sufficient to decrease 
immune function.  
Inflammatory cytokine signals are released during reactions to infection, tissue 
injury, and stress. Lipopolysaccharide challenge in whole blood 48 hours after transport 
indicated there was a statistically significant 40% increase in tumor necrosis factor (TNF) 
α expression, followed by a statistically significant 59% decrease at 96 hours, compared 
with pre-transport baseline values (Carroll et al., 2009). TNF in serum alone has also 
been found to increase after transportation (Van Engen et al., 2014). An increase in 
proinflammatory cytokines (e.g., IL 6 and TNF α) can be attributed to a novel 
environment and can be modulated for 15 to 30 days after arrival (Razzuoli et al., 2016). 
The release of corticotropin releasing hormone is linked to the release of circulating 
immune system proinflammatory cytokines (Hulbert et al., 2011). Description of 
different cytokine profiles is warranted, but there is currently no single marker that is a 
valid indicator of shipping fever outcomes. 
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  Acute phase proteins have been suggested as markers of post-transportation 
stressor events (Arthington et al., 2003). There is a crucial need to develop a valid 
method that can be used to identify cattle requiring or that will require prophylactic 
treatment for BRD. Acute phase proteins released from hepatocytes are potential 
markers, but they have poor functionality as identifiers for specific diseases (Tothova et 
al., 2014). They do provide indications of fulminant and subclinical inflammation and 
when used together may indicate that a disease process is imminent (Ceron et al., 2005). 
Haptoglobin, serum amyloid A, ceruloplasmin, and fibrinogen are the proteins routinely 
investigated for cattle. The investigation of acute phase proteins as markers for potential 
BRD has value. However, the results of a limited meta-analysis indicated that they have 
no diagnostic accuracy for, and are not valid indicators of, BRD (Abdallah et al., 2016). 
When the prevalence of disease is low, acute phase proteins have poor utility as a 
standalone diagnostic tool (Seppa-Lassila et al., 2017). 
  Circulating haptoglobin released from hepatocytes binds free hemoglobin and 
reduces oxidative damage (Murata et al., 2004). Calves inoculated with respiratory 
bacterial pathogens had marked increases in the acute phase protein haptoglobin; this 
protein is a potential diagnostic tool for detection of pulmonary inflammation in calves 
(Hanthorn et al., 2014). Haptoglobin has limited merit for detection of BRD on arrival to 
determine whether targeted prophylactic treatment should be used (Holland et al., 2011). 
Calves with detectable haptoglobin values had significantly higher severity scores and 
rectal temperatures at the first, second, and third treatments and were more likely to be 
treated sooner after arrival (Holland et al., 2011). The release of haptoglobin is a response 
to exogenous corticotropin releasing hormone; this result suggests that it is connected to 
30  
 
stress events (Cooke et al., 2012). Long transportation events lead to a significant 
increase in the release of haptoglobin (Table 2). Haptoglobin has poor utility as a 
biomarker that can be used to distinguish between chronic and acute inflammation 
(Bannikov et al., 2011). Use of haptoglobin and matrix metalloproteinase complexes may 
improve the validity of haptoglobin’s use as a biomarker. Matrix metalloproteinases are 
secreted from numerous immune cells (e.g., macrophages). 
Serum amyloid A has also been implicated as part of acute inflammatory disease 
processes and has potential as a marker for respiratory disease (Alsemgeest et al., 1994). 
The production of serum amyloid A is directly related to inflammatory cytokine 
production, and is usually a response to viral infection (Yamada, 1999). Large increases 
in circulating serum amyloid A concentrations are associated with decreased antibody 
production (Benson and Aldobenson, 1982), enhanced monocyte chemotaxis (Badolato et 
al., 1994), and decreased neutrophil oxidative burst capacity (Linke et al., 1991). The 
serum amyloid A concentration can increase ten-fold by 48 hours after transportation 
(Lomborg et al., 2008). Even when cattle were exposed to only a 3-hour transportation 
event, there was a 46% increase in serum amyloid A concentration over the 7 days 
following transportation (Arthington et al., 2003). Serum amyloid A concentration is a 
sensitive marker for respiratory infection or, through interpretation, the inflammation of 
disease (Orro et al., 2011). 
Ceruloplasmin is a tissue protectant produced during iron-mediated free radical 
injury. It has anti-inflammatory properties and has potential as an indicator of infection 
(Murata et al., 2004). The metalloenzyme concentration is correlated with the serum 
copper concentration and has been suggested as a useful indicator of nutritional copper 
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status for cattle (Pourjafar and Dehkordi, 2008). Investigations of events with infectious 
etiologies have found significant increases in young calves (<30 days of age) clinically 
infected with rotavirus (Rocha et al., 2016). One study found that there was a 28% 
increase in ceruloplasmin concentration at 7 days after shipment in one experiment; a 
48% increase occurred during the 21-d post-transport period in another experiment 
(Arthington et al., 2003). The results of most investigations quantifying ceruloplasmin 
during transportation are consistent with the increasing trend found in the serum. The 
increase in ceruloplasmin has been associated with decreases in growth rates in cattle 
(Cooke et al., 2009). Other studies have found that ceruloplasmin concentration is 
negatively correlated with average daily gain and positively correlated with circulating 
cortisol level (Araujo et al., 2010).  
Fibrinogen is a substrate that allows for fibrin formation; it is key in tissue repair 
by providing support and a binding matrix for the extravasation of cells associated with 
inflammation (Murata et al., 2004). Fibrinogen has been found to increase and decrease 
after transportation. After a long-distance transport by sea and road, calf fibrinogen levels 
were increased by 29% compared with the pre-transport values and were 22% higher than 
the control values (Earley et al., 2012). These increases occur within circulating serum. 
The results for fibrinogen measured within the lung during times of stress indicate that an 
opposite response occurs. Analysis of lung fluid extracted using bronchial alveolar lavage 
in stressed and non-stressed treatment groups revealed a marked decrease in fibrinogen 
12 hours after exposure to the stressor was terminated; this result suggests there was a 
loss of permeability due to the stress-associated release of glucocorticoids and 
catecholamines (Mitchell et al., 2008). There is a stronger correlation between circulating 
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fibrinogen levels and bacterial respiratory pathogens (e.g., M. haemolytica and 
Pasteurella multocida) than to viral pathogens under field conditions (Nikunen et al., 
2007). The critical role of fibrinogen in the bovine is a major focus of disease and clinical 
pathology interpretation for veterinarians.  
Acute phase proteins are a potential hematological identifier of transport stress 
and predisposition to BRD. However, even though general increases occur, 
concentrations can vary between breeds and values be interpreted with caution (Qiu et al., 
2007). Rather than using the change in a singular biomarker, reporting the magnitude of 
changes in multiple circulating markers could be used for decision making. The current 
understanding of acute phase proteins and other proteomics concentrates heavily on a 
small number that are found in high concentrations. The transition to liquid 
chromatography-mass spectrometry screening (LC-MS) for identifying novel proteins at 
lower concentrations may increase the number of potentially useful proteins. 
Mitigation Strategies 
Investigation of methods to alleviate the negative effects of transport and prevent 
morbidity and mortality and enhance receiving performance in the feed yard continues. 
Pre-transportation and on-arrival treatments and methods vary. Most methods are based 
on a nutritional, behavioral, and/or non-antimicrobial pharmaceutical approach. 
Pre-transportation treatment using vitamin A, vitamin D, and vitamin E had no 
effect on shrink associated with transport (Jubb et al., 1993). Investigation of the use of 
vitamin E supplementation on arrival in a population of high-risk calves experiencing 
64.5% morbidity revealed a decrease in the treatment costs associated with the cattle that 
were fed 2000 IU vitamin E (Carter et al., 2000). This article did not report any results 
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indicating increased weight gain or feed efficiency with treatment. However, a study of 
stressed heifers treated using vitamin E after shipment found that at days 14–28 there was 
an increased feed efficiency and average daily gain, but other performance and health 
variables were unaffected (Choat et al., 2000). Trace minerals such as chromium have 
also been administered on arrival as an additive feed supplement in the range of parts per 
million. Chromium supplementation results in increases in average daily gain, 
presumably through increased dry matter intake at differing levels of Cr supplementation. 
The decreases in morbidity that occurred from day 2 to 30 were greatest in the group 
supplemented with 0.2 ppm Cr (Moonsieshageer and Mowat, 1993).  
Nutrition supplements in the form of energy, specific amino acids, and 
electrolytes that are given prior to transportation result in gains in hot carcass weight as 
cattle are transported to harvest (Grumpelt et al., 2015). Supplementation for caloric gain 
in arrival diets from rumen protected poly-unsaturated fatty acids exhibited negative 
effects on weight performance and intake. However, a decrease in circulating haptoglobin 
concentration was a beneficial effect (Araujo et al., 2010). The differences in 
supplementation of a linolenic or a linoleic acid can promote differences in specific 
inflammatory prostaglandin production (Yaqoob and Calder, 2007). Ultimately, the 
differences in the inflammatory mediators could change the immune response to an anti-
inflammatory or inflammatory T cell response.  
Electrolyte supplementation in cattle before transportation helps to mitigate 
changes in osmolality on arrival compared to control animals (Schaefer et al., 1992). 
Compiled evidence was insufficient to substantiate a reduction in stress however 
increased performance at harvest was noted through increased hot carcass weights and 
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decreased live weight loss for treated animals (Schaefer et al., 1997). Multiple-day 
transport durations on a boat are associated with electrolyte benefits in cattle (Beatty et 
al., 2007). Overall, the literature does not support a production or health advantage for 
live cattle entering a feed yard with electrolyte supplementation prior to transportation. 
Most electrolyte research results indicate that there is an added benefit at harvest 
(Schaefer et al., 1997). 
Behavior methods aimed at decreasing morbidity have also been investigated. The 
use of trainer cows for incoming steers upon arrival after transport resulted in an increase 
in performance and health for some of the treatment groups, but overall the results 
between groups were not consistent enough to be conclusive (Loerch and Fluharty, 
2000). Remote early disease identification was used to monitor behavior in calves within 
the first 45 days of arrival at the feedlot (White et al., 2016). This method shows promise 
for detection of calves before the traditional method of visual identification can be used. 
It also identified animals that had lower rectal temperatures. It might be useful for 
identification of animals during the early stages of the disease process (i.e., before 
cytokines are released in response to illness) (White et al., 2015).  
 
Strategies based on the use of pharmacological techniques have also been 
investigated as options to mitigate negative effects (e.g., loss of performance, stress, and 
pain) and promote animal welfare. Some approaches used in older studies have 
aggressively targeted the stress response. Therapeutics involving the use of an adrenolytic 
agent (metyrapone) to suppress cortisol production prior to transportation have been 
studied (Agnes et al., 1990). Metyrapone treatment does not reduce the increase in non-
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esterified fatty acid levels after transportation; the long-term effects were not described. 
Improved veterinary practices for transported animals include the use of nonsteroidal 
anti-inflammatory drugs (NSAIDs). Intravenous administration of flunixin meglumine 
(an FDA approved NSAID for the treatment of pyrexia in cattle) did not restore 
performance on arrival at the feed yard, but the results suggested that it contributed to a 
reduction in cortisol, haptoglobin, and ceruloplasmin until day 4 after transport (Cooke et 
al., 2013a). Flunixin treatment did result in a significant increase in non-esterified fatty 
acid concentrations that persisted through the fourth day after transport, compared with 
the non-treated transport group. The NSAID meloxicam may reduce effects of stress and 
inflammation. An inverse relationship between circulating plasma drug concentration and 
cortisol, neutrophil, and basophil counts has been reported (Van Engen et al., 2014). 
Beyond the suggestion of a decrease in stress and inflammation, there may also be an 
added benefit in terms of increased performance on arrival. Meloxicam-treated calves had 
greater and more efficient weight gain upon arrival. Meloxicam also reduced haptoglobin 
production, compared with an untreated transport group (Guarnieri et al., 2014). The 
translation of these added benefits has not been proven to carry through into the post-
transport period or result in a decrease in morbidity. Additional investigation of 
pharmacological practices that are not associated with metaphylaxis antibiotic treatment 
is warranted.  
Conclusion   
Transport effects vary and so do the subsequent physiological responses. Other variation 
is attributed to differences in age, sex, temperament, and recent environmental exposure. 
Physiologic responses are influenced by multifaceted effects that ultimately begin with 
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dehydration, feed deprivation, tissue damage, and diesel fumes. These connections to 
stress related glucocorticoids and inflammatory cytokines require emphasis during 
research investigation and veterinary communication with producers. Drastic and 
prolonged changes in stress, acute phase proteins and cytokines leads to inflammation 
and immunosuppression. This cascade of factors is attributed to pathogen induced disease 
and decrease of feedlot health.  There is a clear need to develop a model using these 
markers to predict BRD and develop therapeutic measures that concentrate on decreasing 
the aforementioned markers to promote active immune function without the use of 
antibiotics. This goal is attainable through the continued understanding of cattle 
physiologic responses and focusing research on addressing the variables discussed in this 
review. Moving forward, research projects conducted on cattle transportation should 
monitor for BRD and report findings. There is a need for connection of clinical related 
BRD morbidity to these markers. 
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Figure 1. Influence of transportation on bovine respiratory disease. A visual flow 
diagram depicting the intricacies of the role transportation has on generating bovine 
respiratory disease in the feed yard. Arrows connect the hierarchy of cascading effects 
incited by transportation starting with the visually observed and progressing to the 
underlying physiology with in the animal that results in respiratory disease outcomes. 
Boxes or arrows with a dash line represent changes monitored after transport 
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*All arrows in table 1 reference transported animal’s stress biomarker response in 
comparison to either baseline value or a non-transported control group.  
 
 
 
 
 
 
Table 1             
Summary of the scientific literature examining the changes in stress biomarkers during transportation 
  Reference 
Transport 
Duration Study Population Stress Biomarker 
Effect of 
transport* Significance   
   (Price et al., 2015)  2 hours  10 Brahman cows  Cortisol ↑  P<0.001   
  
 (Romero et al., 
2014)  4 hours  65 Zebu steers  Cortisol ↑  P<0.05   
  
 (Van Engen et al., 
2014)  1,316 km 
 97 Brahman cross 
steers  Cortisol ↓  P<0.01   
  
 (Browning and 
Leite-Browning, 
2013)  4 hours  Brahman and Herford  Cortisol ↑  P<0.01   
   (Cooke et al., 2013a)  1,280 km  45 Angus*Hereford  Cortisol ↔  P<=0.09   
   (Cooke et al., 2013b)  1,290 km  63 Angus*Hereford  Cortisol ↑  P<0.01   
  
 (Falkenberg et al., 
2013)  4 hour  22 Holstein heifers  Cortisol ↑  P<0.01   
  
 (Theurer et al., 
2013)  518 km  20 Crossbred heifers  Cortisol ↑  P<0.01   
  
 (Bernardini et al., 
2012)  19 hour  7 Holstein calves  Cortisol ↑  P<0.05   
  (Burdick et al., 2011) 4 hour  15 Brahman bulls Cortisol ↑  P<0.01   
         Epinephrine ↔  NS   
         Norepinephrine ↔  NS   
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  Table 1: Continued   
  Reference 
Transport 
Duration Study Population 
Acute Phase 
Protein 
Effect of 
transport* Significance   
  (Odore et al., 2011)  45 min  32 piedmontese Cortisol  ↑   P<0.001   
         Epinephrine ↑  P<0.05   
         Norepinephrine ↑  P<0.05   
  
 (Buckham Sporer et 
al., 2008)  9 hours 
 12 Angus, 12 Fresian, 
12 Belgian 
blue*Fresian bulls  Cortisol ↑  P<0.001   
   (Gupta et al., 2007)  12 hours  72 Holstein Fresian  Cortisol ↑  P=0.0001   
   (Odore et al., 2004)  950 km    Cortisol ↑  P<0.05   
         Epinephrine ↔ NS   
    Norepinephrine ↑ P<0.05  
 
(Arthington et al., 
2003) 344 km 32 Brahman cross Cortisol ↔ NS  
 (Bulitta et al., 2015) 12 hours Mature cows and bulls Cortisol ↓ P<0.0001  
 
(Gebresenbet et al., 
2012) 
2, 4-6, 10-11 
hours 
Cows, bulls, and 
calves Cortisol ↓ P<0.01  
        
 
*All arrows are in table 1 reference transported animal’s stress biomarkers response in 
comparison to either baseline value or a non-transported control group.  
 
 
 
 
 
 
 
51  
 
 
*All arrows in table 2 reference transported animal’s acute phase protein response 
comparison to either baseline value or a non-transported control group.  
 
 
 
 
 
 
 
Table 2             
Summary of the scientific literature examining the changes in acute phase proteins during transportation 
  Reference 
Transport 
Duration Study Population 
Acute Phase 
Protein 
Effect of 
transport* Significance   
   (Cooke et al., 2013a)  1,290 km 
 63 Angus x 
Hereford   Haptoglobin 
↑ 
P< 0.04   
   (Guarnieri et al., 2014)  1,440 km 
 84 Angus x 
Hereford  Haptoglobin 
↑ 
P< 0.03   
    Ceruloplasmin ↑ P< 0.04  
 (Cooke et al., 2013a) 1,280 km 
45 Angus x 
Hereford Ceruloplasmin 
↑ 
P< 0.03  
    Haptoglobin ↑ P< 0.01  
 (Van Engen et al., 2014) 1,316 km 
97 Brahman x 
Angus Haptoglobin 
↑ 
P< 0.01  
    Fibrinogen ↔ NS  
   (Holland et al., 2011)  957 km 
 360 heifers 
416 steers/bulls  Haptoglobin 
↑ 
P< 0.001   
   (Earley et al., 2013)  18 hours 
 30 Charolais 
Crossbred  Haptoglobin 
↑ 
P<0.05   
   (Marques et al., 2012)  1,200 km 
 45 Angus x 
Hereford  Haptoglobin 
↑ 
P<0.01   
    Ceruloplasmin ↑ P<0.04  
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*All arrows in table 2 reference transported animal’s acute phase protein response 
comparison to either baseline value or a non-transported control group.  
 
 
 
 
  Table 2: Continued             
  Reference 
Transport 
Duration Study Population Acute Phase Protein 
Effect of 
transport* Significance  
   (Earley et al., 2012) 
 2 days 52 continental bulls  Haptoglobin  ↑ P<0.01   
    
     Fibrinogen ↑ P<0.01   
  (Averos et al., 2008)  27 hours  62 young bulls  Haptoglobin ↑ P<0.001   
   (Lomborg et al., 2008)  4-6 hours 
 6 Holstein cows & 2 
Holstein heifers 
 Haptoglobin ↑ P< 0.05   
         Serum Amyloid A ↑ P<0.01   
  
 (Buckham Sporer et al., 
2008) 
 9 hour 
 12 Angus 
 Haptoglobin ↓ P<0.001   
12 Friesian 
      
 12 Belgian Blue x 
Friesian 
 Fibrinogen ↓ P<0.001   
  (Arthington et al., 2003) 344 km 32 Brahman cross Haptoglobin ↓ P=0.04   
     Fibrinogen ↑ P<0.01   
     Ceruloplasmin ↑ P<0.01   
        Serum Amyloid A ↑ P<0.05   
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CHAPTER 3. 
IMPACT OF ORAL MELOXICAM ON CIRCULATING 
PHYSIOLOGICAL BIOMARKERS OF STRESS AND INFLAMMATION IN 
BEEF STEERS AFTER LONG DISTANCE TRANSPORTATION 
 
Modified from a manuscript published in the Journal of Animal Science 
 
N.K. Van Engen,* M.L. Stock ,† T. Engelken,‡ R. C. Vann,§ L.W. Wulf,** L. A. 
Karriker,‡ W.D. Busby,†† J. Lakritz,‡‡ A.J. Carpenter,
§§
 B.J. Bradford,***  W. Hsu, C. 
Wang,‡ J. F. Coetzee*** 
 
Abstract 
Transportation stress can result in significant economic losses to producers due to 
decreased animal productivity and increased medication costs associated with sickness 
such as bovine respiratory disease (BRD). Meloxicam (MEL) provides pain relief and 
anti-inflammatory effects in cattle for several days after a single oral treatment. Our 
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hypothesis was that MEL administration before shipping would reduce the impact of long 
distance transportation on circulating physiological biomarkers of stress and 
inflammation in beef steers.  Ninety-seven beef steers were blood sampled for baseline 
biomarker determination and then randomly assigned to receive either 1 mg/kg MEL (n = 
49) or a placebo (CONT) (n = 48) per os prior to a 1,316-km transportation event lasting 
approximately 16 h. Calves were then blood sampled on arrival and 5 d later. Changes in 
the hemogram, circulating plasma proteins, total carbon dioxide (TCO2), fibrinogen, 
substance P (SP), cortisol, haptoglobin (Hp)-matrix metalloproteinase-9 (MMP-9) 
complexes and tumor necrosis factor alpha (TNFα) between treatments over time were 
compared using a Mixed Effects Model with statistical significance designated as P < 
0.05. ANCOVA was conducted to assess the relationship between circulating MEL 
concentrations and biomarker changes over time. An increase in neutrophil, platelet, 
monocyte, white blood cell and red blood cell counts occurred after transportation (P <  
0.0001) and a decrease in lymphocyte count was observed (P < 0.0001). MEL treatment 
reduced the stress-induced neutrophilia (P = 0.0072) and circulating monocyte count (P = 
0.013) on arrival. Mean corpuscle hemoglobin (P = 0.05), mean corpuscle volume (P = 
0.05) and lymphocyte count (P = 0.05) was also greater in the CONT calves compared 
with MEL calves after transportation. Furthermore, HP-MMP-9 complexes, TCO2, 
TNF, plasma proteins and SP increased and cortisol decreased after shipping (P < 0.01). 
MEL treatment tended to reduce serum cortisol concentrations (P = 0.08) and there was 
evidence of a time-by-treatment interaction (P = 0.04).  An inverse relationship between 
plasma MEL concentrations and circulation cortisol concentrations (P = 0.002), 
neutrophil (P = 0.04) and basophil counts (P = 0.03) was also observed. The results 
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suggest that MEL administration may reduce the impact of long-distance transportation 
on circulating physiological biomarkers of stress and inflammation in beef calves. 
Introduction 
Transportation of calves intended for beef production is a common practice. In the 
United States, at least 65% of calves are shipped to feedlots in Texas, Kansas, Nebraska 
and Colorado, usually by truck, due to a geographical separation between calf rearing and 
finishing facilities (Swanson and Morrow-Tesch, 2001; USDA, 2009). 
Immunosuppression after transportation predisposes calves to developing BRD, which 
commonly occurs in the first 45 d of arrival and is associated with 65 to 80 % morbidity 
and 35 - 55 % mortality (Cernicchiaro et al., 2012; Edwards, 1996; Speer et al., 2001). 
BRD is estimated to cost the beef industry $500 million annually (Miles, 2009). 
Therefore, even a modest reduction in stress after transportation could have a significant 
economic benefit for livestock producers (Speer et al., 2001).  
Transportation is associated with an increase in circulating pro-inflammatory 
cytokines in cattle leading to the initiation of an inflammatory reaction (Arthington et al., 
2003). Previous studies support the hypothesis that extended exposure to a non-steroidal 
anti-inflammatory drug (NSAID) may reduce stress and improve performance after 
castration and dehorning (Baldridge et al., 2010; Coetzee et al., 2012b). Meloxicam is an 
NSAID approved in Canada for pain relief in calves after disbudding and is used as an 
anti-inflammatory for dogs in the United States. Meloxicam was found to reduce the 
incidence of BRD in calves after castration when administered on arrival at the feedlot 
(Coetzee et al., 2011).  However, a similar effect was not observed in calves received as 
steers. We hypothesized that MEL administration to beef steers before shipping may be 
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effective at reducing the impact of transportation on stress biomarkers. The objective of 
this study was to assess stress biomarkers and inflammatory mediators in beef steers that 
received oral MEL or a CONT before long distance transportation.   
Materials and Methods 
Before the initiation of this experiment, all animal use, handling, and sampling 
techniques described were approved by the Iowa State University Animal Care and Use 
Committee (IACUC protocol # 5 – 12 – 7355 - B).  
Animals, Housing, Treatment Allocation, and Shipment  
This study was a randomized complete block design with cattle assigned to 
receive either oral meloxicam (MEL) or a whey protein placebo (CONT) prior to 
shipment based on bodyweight (Figure 1). Ninety-seven medium-large frame, horned & 
polled, Brahman, and Angus X Brahman crossbred steers aged 15 – 17 mo, weighing 201 
to 465 kg were procured from the Brown Loam Experiment Station at the Mississippi 
State University research farm near Raymond, MS after a 32 wk backgrounding period. 
All calves received preweaning vaccinations for infectious bovine rhinotracheitis, bovine 
viral diarrhea types I and II, parainfluenza-3 virus, bovine respiratory syncytial virus 
(Pyramid 5, Boehringer Ingelheim, St. Joseph, MO) clostridial organisms (Ultra bac 7, 
Pfizer Animal Health, Madison, New Jersey), and Mannheimia haemolytica (One Shot, 
Pfizer Animal Health, Madison, New Jersey) and were dewormed at the facility with 
eprinomectin (Eprinex, Merial, Duluth, Georgia). Post weaning vaccinations consisted of 
a booster for all pathogens stated prior to the start of the backgrounding period. 
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 Following weaning in October 2011, calves were held for 60 d in Brown Loam 
Research Facility in Raymond, MS feedlot. Calves were initially fed a diet of soy hull 
pellets at 2% of their BW followed by free choice hay and 20% crude protein molasses. 
Animals were then maintained on ryegrass pastures until late June when they were 
allowed access to crabgrass and Bermuda grass pastures prior to shipping. If pasture was 
limited at any point in time hay was provided. The hay in both instances contained mixed 
grasses but primarily consisted of Bermuda grass.  
Baseline blood sample collection occurred at time point 0 which was immediately 
followed by administration of meloxicam or the placebo. Calves were ranked by BW and 
assigned to either a MEL or CONT-treated group by a randomization table generated 
using Excel (Microsoft Corp., Redmond, WA). To facilitate dose determination and to 
minimize disruption during processing, calves were subdivided into 3 groups based on 
weights determined at study enrollment. These groups were as follows: light (201 - 314 
kg), medium (319- 370 kg), and heavy (380 - 465 kg) weight. At time zero (0 h) MEL 
tablets (MEL Tablets USP 15 mg [NDC 0378 – 1089 - 01], Mylan Pharmaceuticals Inc. 
Morgantown WV; Lot # 3032625) were administered to the three groups so that the 
average weight per group resulted in a mean dose of 1 mg meloxicam/kg BW. The doses 
were calculated using pretreatment BW from the previous wk in addition to adjusted 
weight gain during that wk. When weighed, no restrictions to food or water were 
implemented. The light group (n = 31) received an actual dose of 0.9 to 1.4 mg/kg BW.   
The medium group (n = 33) received an actual dose of 0.89 to 1.0 mg/kg BW, and the 
heavy group (n = 33) received an actual dose of 0.90 to 1.1 mg/kg BW. Calves in the 
CONT-treated group received an equivalent dose of whey protein supplement product 
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(Health-watchers, inc. Bohemia, NY), a pharmaceutically inactive excipient used in the 
manufacture of MEL tablets. Both treatments were administered in gelatin capsule 
boluses (Torpac, Fairfield, NJ; Lot # 2634). Whey protein was also added as filler to the 
capsules containing meloxicam tablets so that operators remained masked to treatment 
group.  
After treatment, calves were shipped approximately 1,316 km from Raymond, 
MS a feedlot facility near Tabor, IA in 2 truckloads carrying 48 and 49 calves 
respectively. Loading was coordinated for the trucks to arrive at the 24 h time point. 
Calves were blood sampled in Iowa on 10 July 2012 after a 16 h transportation event that 
concluded approximately 24 h after baseline blood collection. Calves were then 
maintained in an open pen 192 m2 with an allowance of approximately 0.69 m of bunk 
space per animal and one water source per pen. All calves were housed in the same pen. 
Upon arrival calves were fed a typical receiving diet composed of dry corn, dry distiller's 
grain, corn silage, and a protein/vitamin/mineral supplement throughout the 
experiment.  Feed and water were offered ad libitum. A final blood sample was collected 
at 5 d after arrival, 144 h after baseline sample collection at 0 h.  
Collection of samples 
Blood samples were collected at 0 h, 24 h, and 144 h via direct puncture of the 
jugular vein to assess complete blood count (CBC) and to determine plasma 
concentrations of MEL, total carbon dioxide (TCO2), haptoglobin (Hp)-matrix 
metalloproteinase-9 (MMP-9) complexes, tumor necrosis factor alpha (TNFα), cortisol, 
and substance P (SP). Blood samples were collected in 6 ml evacuated tubes that 
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contained lithium heparin (Vacuette Heparin tubes, Greiner Bio-One, Monroe, NC) 
(MEL and cortisol concentrations), serum separator tubes (Vacuette SST tubes, Greiner 
Bio-One, Monroe, NC) (TCO2, TNF, Hp-MMP 9) or EDTA tubes (Vacuette K3 EDTA 
tubes, Greiner Bio-One, Monroe, NC) (CBC and SP concentrations). Benzamidine 
hydrochloride (Santa Cruz Bio Technology, Dallas, TX; Lot # D1510), was added to one 
of the EDTA tubes at 1 mM per mL of whole blood to reduce endogenous protease-
associated degradation of SP in the samples. Blood samples were centrifuged for 15 min 
at 1,600 x g. All samples were processed within 30 min of collection. Immediately after 
centrifugation, plasma was harvested, placed in cryovials, and frozen at –70C until 
analysis.  
Plasma Meloxicam Analysis  
 Plasma concentrations of MEL were determined using high-pressure liquid 
chromatography (Surveyor MS Pump and Autosampler, Thermo Scientific, San Jose, 
CA, USA) with mass spectrometry detection (TSQ Quantum Discovery MAX, Thermo 
Scientific, San Jose, CA, USA) as previously described (Kreuder et al., 2012). The 
accuracy of the assay for MEL in bovine plasma was 99 ± 3% of the actual concentration 
while the coefficient of variation was 5% determined on 4 sets of replicates for each of 
the following concentrations: 15, 150, and 1500 ng/mL. 
Cortisol Analysis 
Plasma cortisol concentrations were determined by RIA using a cortisol kit 
(Siemens Coat-a-Count Kit, Siemens, Malvern, PA) according to manufacturer 
instructions.  The range of detection was from 3 to 1000 ng/mL. The coefficient of 
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variation for intra assay variability was 10% and the inter assay variability was calculated 
< 15% 
Substance P Analysis 
Substance P concentrations were analyzed as described by Liu et al. (2008) using 
non-extracted plasma. Method validation using non-extracted plasma consisted of 
complete recovery (± 15 %) of a known SP concentration added to pooled baseline 
plasma.   Plasma concentrations of SP were analyzed by RIA using double antibody 
system with a primary antibody vs. SP (1:60,000, purchased from Phoenix 
Pharmaceuticals, Burlingame, CA (Lot # H-061-0) and 125 I-substance P (20,000 cpm) 
purchased from PerkinElmer Inc (Waltham, Massachusetts, USA).  EDTA (13 
mM). Immunoassays have been utilized previously to determine SP concentrations and 
have been validated for use with bovine plasma (Coetzee et al., 2008; Theurer et al., 
2013). The assay had a determination range of 5 to 160 pg/ml. The coefficient of 
variation for intra assay variability was at 11 % and the inter assay variability was 
calculated at 4 %. 
Total serum carbon dioxide analysis 
Total carbon dioxide concentration (T CO2) was analyzed using the serum 
collected from steers at 0 h and 24 h. Samples were centrifuged immediately after 
collection and all analyses were completed within 48 h after collection to minimize the 
effect of sample handling on total CO2 concentrations (Tinkler et al., 2012). The samples 
were analyzed using Nova 4, a total CO2 analyzer (Nova Biomedical, Waltham 
Massachusetts), following manufacturer’s instructions. Data analysis was completed 
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through the use of a known carbon dioxide standard kit (Verichem Laboratories, 
Providence, Rhode Island).  
TNF Analysis 
Tumor Necrosis factor α was analyzed using a bovine TNF ELISA test that was 
previously validated by Farney et al. (2011).   The optical density was then measured at 
450 and 550 nm using a plate reader (PowerWaveXS; BioTek Instruments Inc., 
Winooski, VT). The corrected difference values were fit to the standard curve by point-
to-point regression. Values of detection ranged from 3.9 to 250 pg/mL with intra-assay 
and inter-assay critical variances of 14.1 % and 15.9 %, respectively. 
 
Hp-MMP 9 Analysis 
An ELISA specific for bovine neutrophil haptoglobin in complex with matrix-
metalloproteinase 9 (Hp-MMP 9) was performed as described previously (Bannikov GA 
et al., 2011) with minor alterations. Standard concentrations ranged from 1.78 ng/mL to 
456 ng/mL which represent the upper and lower limits of quantitation of the assay 
respectively. The concentration of Hp-MMP 9 was determined using the linear portion of 
the equation of the line described by absorbance of the calibrators at 450 nm and the 
known concentration of these calibrators.  Any sample remaining outside of the range of 
the standard curve ( > 456 ng/mL) were diluted further and re-analyzed.  Between plate 
variability of calibrators from five plates was less than 3 % (median = 1.8 %; range 0.98-
2.7 %).  The average correlation coefficient determined by linear regression of the 
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absorbance versus concentration of the calibrators was 0.91 (range 0.85 to 0.95).  The 
analytical sensitivity of the assay was 3.5 ng/mL.  
Clinical pathology analysis 
 The Iowa State University Clinical Pathology Laboratory determined the CBC 
using the ADVIA 120 analyzer (ADVIA 120, Siemens, Malvern, PA) using a program 
specific for bovine blood. This automated process measures total white blood cell count, 
white blood cell differential, red blood cell count, platelet counts, hemoglobin, 
fibrinogen, mean corpuscle volume (MCV), mean corpuscle hemoglobin concentration 
(MCHC), mean corpuscle hemoglobin (MCH), red blood cell distribution width (RDW), 
and hematocrit.  
Statistical Analysis 
The statistical analysis of the study was performed using SAS (Version 9.2, SAS 
Institute, Inc., Cary, NC). Responses were analyzed using linear mixed models with 
repeated measures. Animal was the subject of repeated measures whereas Truck was 
included in the model as a random effect. Two structures of fixed effects were 
considered. One is analyses of variance (ANOVA) structure with treatment group, time 
and their interaction; the other is an analysis of covariance type (ANCOVA) with MEL 
concentration (continuous) and time (categorical) included in the model. Furthermore, 
MMP values were analyzed following quantification of MMP as either having the 
presence (“yes”) or absence (“no”) of the protein in measurable quantities. A mixed 
effect logistic regression model that contained repeated measures was used to describe 
the data.  
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Model assumptions were considered to be appropriately met based on diagnostics 
conducted on studentized residuals. Estimated least square means and corresponding 
standard errors, or 95% confidence intervals, are presented. A significant difference was 
considered to be present when P  ≤  0.05, and a marginal difference was considered to 
exist if 0.05  <  P  ≤  0.10.  Relevant pairwise comparisons were conducted when the 
significance of the interaction term was P  ≤  0.10 using Tukey-Kramer or Bonferroni 
adjustments, as appropriate in each case, to avoid inflation of Type I error rate due to 
multiple comparisons.   
Results and Discussion 
 Meloxicam is an NSAID of the oxicam class that is approved in the European 
Union and Canada for adjunctive therapy of acute respiratory disease, diarrhea, and acute 
mastitis and the alleviation of pain associated with disbudding in calves when 
administered at 0.5 mg/kg intravenously (IV) or subcutaneously (SC) (EMEA, 2009). 
Meloxicam administered to cattle by any route constitutes extra-label drug use (ELDU) 
because there are currently no analgesic drugs specifically approved to provide pain or 
stress relief in livestock in the United States (Smith and Modric, 2013). Under the Animal 
Medicinal Drug Use Clarification Act, 1994 (AMDUCA), ELDU is permitted only under 
veterinary supervision “when the health of an animal is threatened, or suffering or death 
may result from failure to treat” provided specific conditions are met (US Food and Drug 
Administration, 1994). In the absence of FDA-approved analgesic compounds in food 
animals, use of oral meloxicam tablets for alleviation of pain or stress in cattle can be 
considered under AMDUCA. To our knowledge, this is the first published report 
evaluating the effect of a long-acting NSAID on the stress response in cattle after long-
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distance transportation. Further studies are needed to assess if this translates to improved 
health and performance on arrival at the feedlot. 
Plasma meloxicam concentrations 
 None of the calves had detectable plasma meloxicam concentrations in samples 
collected at the baseline time point. Mean (±SEM) plasma meloxicam concentrations in 
MEL-treated calves ranged from 1,868 ± 92.16 ng/mL on arrival at the feedlot (24 h after 
dosing) to 38.38 ± 6.18 ng/mL at 144 h after dosing. There was no difference in plasma 
meloxicam concentrations between the 3 different weight categories of calves that were 
used for dose determination (P = 0.90). There were also no meloxicam detected in calves 
assigned to the CONT group. 
The pharmacokinetics of meloxicam after oral administration at 1 mg/kg indicate 
that a peak plasma concentration (Cmax) of approximately 3 μg/mL occurs at around 12 
h after administration (Tmax) with an elimination half-life (T ½) of about 28 h (Coetzee 
et al., 2009, 2011). In the present study, the mean meloxicam concentration determined at 
24 h after oral administration was less than the peak concentration previously reported. 
However, the mean concentration of meloxicam recorded at 144 h represents a T ½ of 
approximately 24 h and is consistent with the level expected after approximately 5 to 6 
plasma elimination half-lives. Taken together the results of this study suggest that 
meloxicam administered at 1 mg/kg provided circulating meloxicam concentrations for 
up to 5 d after oral administration.  
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Body weight (BW)  
Calves experienced a characteristic decrease in BW after the transportation event 
known as “shrink.” This weight loss was reported as a time effect (P < 0.001) with no 
treatment effect observed between groups (P = 0.67) (Figure 2). Furthermore, there was 
no association between plasma MEL concentrations and shrink (P = 0.78) (Table 4). 
These results are consistent with previously reported studies evaluating weight loss 
following transportation from a North American review on animal welfare 
(Schwartzkopf-Genswein et al., 2012). The observed weight loss in this study is 
consistent with previous reports in the literature. However, the calves in our study 
showed an 8 % loss in BW where as Arthington and others (2003) reported a 2 to 3 % 
loss in BW after a 3 h transportation event and Buckham Sporer et al. (2008) reported 
shrinkage of 10 % in calves (approx. 230 kg) transported for over 9 h. This supports the 
hypothesis that percentage of weight loss during transportation is likely associated with 
the duration of the transportation event as was previously suggested (Cernicchiaro et al, 
2012). 
Cortisol 
Serum cortisol concentrations were affected by time (P < 0.0001) in both the 
MEL and CONT groups. The concentration of cortisol decreased from baseline to 24 h 
after transportation and increased marginally at the 144-h sample collection (Figure 3). 
The present study provided evidence of a time-by-treatment interaction on cortisol 
response (P = 0.04) and an inverse relationship between circulating cortisol 
concentrations and MEL concentrations (P = 0.0017) (Table 4).   
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The decrease in cortisol observation contradicts previous published reports that 
demonstrate an increase in cortisol ranging from 5.8 % in 2 to 3 wk mixed breed calves 
transported for 8 to 24 h in duration (Knowles et al., 1997) to 311 % in 4 to 6 mo old 
dairy calves transported for 4 h (Murata et al., 1987). Elevated cortisol concentrations in 
serum are maintained after exogenous ACTH stimulation for approximately 2 h (Lay et 
al., 1996). The longer travel time in the present study may have allowed calves to become 
acclimated to their surroundings, thus reducing blood cortisol levels while on the truck in 
transit. Moreover, the sample obtained at 24 h may not have coincided with peak cortisol 
concentrations following transportation. 
  The observed time by treatment effect was likely due to the combined anti-
inflammatory and analgesic effect of NSAIDs in addition to a proposed direct modulation 
of ACTH release resulting in a reduction in circulating cortisol concentrations (Watson et 
al., 2009). Recently, Geary (2012) reported that circulating cortisol concentration in cows 
receiving the NSAID flunixin meglumine was numerically less than control cows after 
injection of ACTH to mimic transportation stress. It is likely that this study, which only 
comprised 20 animals, lacked sufficient statistical power to detect a significant difference 
between groups.  Taken together the relationship between NSAID administration and 
stress reduction after transportation warrants further investigation in order to determine if 
this results in improved health and performance of calves after long-distance 
transportation.  
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Haptoglobin-Matrix Metalloproteinase 9 (Hp-MMP 9) complexes 
The majority of the serum samples contained < 15 ng/mL Hp-MMP 9 complexes 
(253 / 288 samples).  Therefore, in addition to conducting a repeated measures analysis 
on the positive results, we also chose to classify samples as positive or negative based on 
the cutoff of <15 ng/mL (negative) and > 15 ng/mL (positive).   Overall 2.1 % of the 
calves were positive at first sampling time, 15.6 % were positive at 24 h after arrival and 
18.9 % were positive at 4 d after arrival. However, using this analysis there was no effect 
of treatment (P = 0.97), time (P = 0.88) or time-by-treatment interaction (P = 0.59).  
In the calves that did demonstrate quantifiable increases in Hp-MMP 9 
complexes, a time effect (P = 0.0061) was observed in both treatment groups (Figure 4) 
but no treatment effect (P = 0.88) was observed. There was also no evidence of a 
relationship between MEL concentrations and logHp-MMP-9 (P = 0.74) (Table 4).  
Matrix metalloproteinases regulate the degradation of extracellular matrix protein 
components and modulates cytokine activation through in-vivo cleavage.  Bannikov et 
al., (2007) reported that neutrophil MMP-9 is covalently complexed with neutrophil 
synthesized haptoglobin suggesting that this is a potentially useful biomarker indicating 
activation and degranulation of neutrophils (Theurer et al., 2013).  Increases in plasma 
Hp-MMP-9 concentration over time are consistent with other studies reporting 
significantly elevated plasma Hp-MMP-9 concentrations in cattle with acute 
inflammation (Bannikov et al., 2011). A number of disorders commonly diagnosed in 
cattle are characterized by a significant mobilization and activation of neutrophils 
(Slocombe et al., 1985). The present study documents for the first time that plasma 
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concentrations of Hp-MMP 9 are associated with physiologic alterations during 
transportation.   
Fibrinogen 
 Circulating fibrinogen concentration was not significantly affected by 
transportation (P = 0.17) or MEL administration (P = 0.41) (Table 1). There was also no 
association between MEL concentrations and fibrinogen (P = 0.42) (Table 4). 
 Fibrinogen maintains homeostasis by providing a substrate for fibrin formation 
and tissue repair (Murata et al., 2004). Fibrinogen results for cattle during transportation 
remain equivocal.  A 133 % increase in fibrinogen was reported in a study with 32 calves 
that were transported for 3 h (Arthington et al., 2003).  Conversely, a 28% reduction in 
fibrinogen over 48 h after transportation was reported in a study involving 36 calves 
transported for 9 h (Buckham-Sporer et al., 2008). Therefore the usefulness of fibrinogen 
as a biomarker of inflammation after transportation requires further investigation.  
Plasma Protein 
Plasma protein concentrations increased over time after transportation (P < 
0.0001) most notably at the 24 h sampling time point (P < 0.001) as illustrated in Table 1. 
Plasma protein was unaffected by treatment (P = 0.32) and there was no association 
between plasma MEL concentrations and plasma protein (P = 0.32) (Table 4). 
 Hyperproteinemia was anticipated after transportation as a result of dehydration 
due to inadequate water intake and water loss during shipping. This observation is in 
agreement with previous reports (Parker et al., 2003; Earley et al., 2006a; Earley and 
O’Riordan, 2006b). However, another study reported a decrease in plasma protein after a 
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9 h transportation event (Buckham Sporer et al., 2008). This was attributed to altered 
protein metabolism associated with transportation or differences in the nutritional status 
of animals immediately before transportation. It was also reported that breed may 
influence plasma protein concentrations but these effects could not be established in the 
present study.   
Tumor Necrosis Factor alpha (TNF) 
A significant increase in circulating TNF concentrations was observed after 
transportation (P < 0.001) (Figure 5). However, there was no effect of MEL 
administration on TNF concentration (P = 0.79). There was also no association between 
plasma MEL concentrations and TNF concentrations (P = 0.96) (Table 4).  
Cytokines are signaling proteins produced primarily by macrophages in response 
to infection, tissue injury or stress. Elevated levels of TNF increase vascular 
permeability of endothelial cells, which allows for the increased entry of 
immunoglobulin, complement and other cells to damaged tissue (Janeway et al., 2012). 
An increase in cytokine production after transportation was anticipated based on a recent 
publication that reported a 40% increase in TNFα at 48 h after a 4h transit event (Hulbert 
et al., 2011). Although a recent study indicated a reduction of TNF in calves with BRD 
treated with MEL and oxytetracycline, a treatment effect was not observed in the present 
study (Bednarek et al., 2003).  The direct mechanism behind this effect is poorly 
understood and requires further investigation. 
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Substance P 
An increase in plasma SP concentrations was observed after transportation (P < 
0.0026) (Figure 6), but there was no treatment effect (P = 0.13) or time by treatment 
interaction (P = 0.45). There was also no association between plasma MEL 
concentrations and SP (P = 0.89) (Table 4).  
Substance P is an 11- amino acid neuropeptide associated with areas of the 
neuroaxis involved in the integration of pain, stress, and anxiety (Devane et al., 2001; 
Coetzee et al., 2008).  The present study supports the results of a recently reported 46% 
SP increase following 4 h of transportation (Theurer et al., 2013). Although an inverse 
linear relationship of meloxicam and SP has been recently reported in a dehorning study 
(Coetzee et al., 2012), MEL administration did not reduce SP in the present study. The 
absence of an effect could be associated with a reduced magnitude of SP release after 
transportation compared with dehorning.   
A wide variety of physical and psychological stressors can stimulate release of 
SP. Pulmonary exposure to diesel exhaust fumes, ozone, allergens, carbon dioxide and 
cigarette smoke can elicit SP release in airways in rats (Wong et al., 2004a; Wong et al., 
2004b). The role of SP in the pathogenesis of BRD has yet to be elucidated.  In 
experimental M. haemolytica infection in sheep there was strong immunoreactivity for SP 
on macrophages infiltrating into the inflamed areas on d 1 post-infection (Ramirez-
Romero et al., 2001; Grubor et al., 2004).  Furthermore, exposure of alveolar 
macrophages to SP resulted in enhanced phagocytosis and TNF production compared to 
non-stimulated controls (Rogers et al., 2006). An increase in vascular permeability in 
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response to SP exposure has also been demonstrated (Ragsdale et al., 2008).  Taken 
together these studies indicate that transportation increases SP release and that this may 
be associated with the development of pulmonary inflammation that may contribute to 
the pathogenesis of BRD. However, administration of an NSAID appeared to be 
ineffective at directly mitigating SP release after shipping in the present study. 
Total CO2 
There was an increase in total CO2 (TCO2) during transit (P < 0.0001) (Table 1) 
but there was no treatment effect (P = 0.51) or association between plasma MEL 
concentrations and TCO2 (P = 0.90) (Table 4).  
An increase in TCO2 after shipping has been previously reported as a result of a 
decrease in potassium, chloride and water from sweating (Stockham et al., 2008).  
However, in a study investigating the partial pressure of carbon dioxide (pCO2) after 
transportation, no difference was reported for transported steers compared to control 
animals (Parker et al., 2003).  TCO2 of serum or plasma provides a measure of acid-base 
balance due to metabolic changes. The increase in TCO2 observed in the present study is 
likely indicative of either a metabolic or respiratory alkalosis (Dehkordi and Dehkordi., 
2011). Metabolic alkalosis is most frequently associated with digestive disturbances in 
ruminants. Respiratory alkalosis is caused by hyperventilation, which may be stimulated 
by pulmonary disease or heat stress. Both types of alkalosis may therefore be present 
during long distance transportation where animals are subjected to food deprivation and 
exposed to changes in environmental temperature.    
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Hematology 
Time effects were observed for all hematological data (P < 0.05), except for 
basophil count (P = 0.84) and mean corpuscle hemoglobin concentration (MCHC) (P = 
0.45) (Table 3). Treatment effects were observed for total leukocyte counts (P = 0.01), 
mean corpuscle volume (P = 0.05), mean corpuscle hemoglobin (P = 0.05), and 
lymphocyte count (P = 0.05) (Table 2). A time by treatment interaction was evident for 
monocyte count (P = 0.04) and a trend towards an interaction was observed for red blood 
cell distribution width (RDW%) (P = 0.07) and neutrophil count (P = 0.10).  
A stress leukogram, characterized by a mature neutrophilia, lymphopenia, and 
monocytosis, was observed in both groups following transportation. The administration 
of MEL appeared to attenuate the development of a stress leukogram as evidenced in the 
response variables discussed below.   
A neutrophilia (P < 0.0001) observed across both groups after transportation 
(Figure 7) is consistent with results from previous studies (Blecha et al.,1984; Buckham 
Sporer et al., 2008; Burdick et al., 2011).  The increase in the mean number of circulating 
neutrophils recorded in the CONT group upon arrival at the feedlot was greater than in 
the MEL group (P = 0.0072) (Table 2).  Neutrophil count was also inversely proportional 
to plasma MEL concentrations providing further evidence of a treatment response (P = 
0.04) (Table 5).  
A stress neutrophilia is the result of the corticosteroid-induced release of mature 
cells from the bone marrow and the reduced margination and migration of neutrophils out 
of the vasculature (Benschop et al., 1996; Jones et al., 2007).  Several studies have 
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determined the functional capacity of the immune response using in vitro tests after 
transport. Murata et al. (1987) observed that nitroblue tetrazolium reduction activity of 
neutrophils was initially reduced by 10 % on arrival followed by a 36 % increase at 4 h 
after transport.  Similarly, Burdick and others (2011) found that cattle had decreased 
phagocytic neutrophil intensity at 48 h post-transit and that calm bulls had more active 
neutrophils with greater phagocytosis and oxidative burst intensities to E. coli than 
temperamental bulls at 96 h. These findings indicate that, although the relative number of 
neutrophils is increased after transportation, the functional capacity of these cells is 
decreased leading to immune compromise. The mitigation of the stress neutrophilia in the 
present study and the negative association between MEL concentrations and neutrophil 
count suggests that MEL may have reduced some of the negative impacts of 
transportation stress on immune function. Further studies evaluating immune cell 
function are planned to characterize this effect further.      
Lymphocyte counts decreased from before shipping to arrival in both the CONT 
(P < 0.0001) and MEL (P < 0.0005) groups (Table 2). A further reduction in lymphocyte 
count was observed between arrival and 120 h later in both the MEL (P = 0.01) and 
CONT (P = 0.0001) groups. The reason for the observed treatment effect of MEL was 
likely due the greater lymphocyte count in the CONT calves before shipping because no 
time by treatment interaction was evident (Figure 8).  
Exposure to corticosteroids causes redistribution of circulating lymphocytes into 
lymphoid compartments resulting in the development of a lymphopenia (Burton and 
Kehrli., 1996). Murata et al. (1987) reported a 90 % decrease in T-lymphocyte numbers 
of 4 to 6 mo old calves transported 4 h but no change in the number of B lymphocytes. 
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Buckham Sporer et al. (2008) reported a 20 % increase in leucocyte count from 4.5 to 14 
h after initiation of a 9 h transportation event followed by a decrease ranging from 7 to24 
% at 24 and 48 h, respectively. Hubert et al. (2011) reported an 86 % increase in the 
neutrophil: mononuclear cell ratio at 24 h post-transit. This observation is similar to the 
results of the present study and is consistent with the development of a stress leukogram 
after transport. 
Monocyte counts increased from before shipping to arrival in the CONT (P < 
0.0001) but not the MEL (P = 0.18) group (Table 2; Figure 9). Exposure to 
corticosteroids also causes mobilization of marginated monocytes within the vasculature 
resulting in the development of a monocytosis (Latimer and Prasse., 2003). Burdick et al. 
(2011) reported an 8 % increase in peripheral mononuclear cells after a 4 h transportation 
event (P = 0.056). This observation is similar to the results of the present study and is 
consistent with the development of a stress leukogram after transport. The concurrent 
mitigation of both the monocytosis and neutrophilia in the present study provides further 
support for the hypothesis that MEL reduced some of the negative impacts of 
transportation stress on immune function.  
Basophilia in mammalian blood smears is seldom dramatic but an increase in 
circulating basophil count has been associated with stress in birds (Latimer and Prasse., 
2003). In the present study there was no effect of time or treatment on basophil count 
(Table 2). However, there was a negative association between circulating MEL 
concentration and basophil count (P = 0.03) (Table 5). To our knowledge there have been 
no studies that have specifically investigated the effect of transportation on basophil 
count. Given the absence of an overall effect of treatment and transportation despite a 
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negative association with MEL, basophils appear to have limited utility in assessing 
stress in cattle.    
A treatment effect was evident for both MCH (P = 0.05) and MCV (P = 0.05) 
with an observed decrease in MEL calves compared to CONT calves (Table 3). Although 
values remained in the laboratory’s reference range for normal limits, this effect may be 
the result of decreased synthesis of prostaglandin E2 (PGE2) associated with 
cyclooxygenase inhibition after NSAID administration.  PGE2 has demonstrated both 
enhancement and maintenance of haemopoietic stem cell activity and increases in MCH 
and MCV are usually associated with hematopoiesis (North et al., 2007; Hogatt et al., 
2009). Therefore, compounds that decrease PGE2 synthesis could potentially decrease 
stem cell activity resulting in a decreased MCH and MCV.  
A time-by-treatment interaction was evident in RDW% (P = 0.07) with the 
distribution width being less in CONT calves compared with MEL calves (P = 0.03) on 
arrival (T24) (Table 3). There was no effect of time on RDW% in the MEL-treated 
group.  However, a weak positive association between MEL concentrations and RDW% 
(P = 0.07) was observed.   
RDW % is a measure of variation in the size of the red blood cells. It is a 
calculated parameter representing the co-efficient of the variation of the Mean 
Corpuscular Volume (MCV) (Subhashree et al., 2013). It is thus not surprising that a 
difference in RDW % was observed in the present study because MCV was less in MEL-
treated calves (P = 0.05). In a previous study Fazio and others (2011) observed an 
increase in RDW % in sheep transported 125 km by road for 3 h but no explanation was 
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offered for why this observation occurred.  It has been suggested that an increase in RDW 
% can be used as a biomarker to identify pulmonary compromise but the conflicting 
results presented in these reports suggest that additional studies are needed to investigate 
this relationship further.  
 The overall results of this study suggest that long distance transportation was 
associated with a significant increase in neutrophil, platelet, monocyte, white blood cell 
and red blood cell count after shipping and a decrease in lymphocyte count. Furthermore, 
MMP-9 complexes, TCO2, TNF, plasma proteins and SP increased and cortisol 
concentrations decreased after shipping. MEL treatment reduced the stress neutrophilia 
and monocytosis after shipping. Circulation cortisol, neutrophil and basophil 
concentrations were also inversely proportional to plasma MEL concentrations. Further 
studies, including examination of the effect of MEL administration on cell function, calf 
health and performance, are needed to fully elucidate the overall impact of NSAID 
administration on the negative effects of long-distance transportation. These findings may 
have implications for developing strategies to reduce the impact of transportation stress 
on the health and performance of feedlot cattle 
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Table 1. Comparison between the least squares (LS) means ± SE serum chemistry 
biomarkers at 0, 24 and 144 h after treatment (trt) with 1 mg/kg meloxicam (MEL) or a 
Placebo (CONT) before transportation. 
 
a,b Different superscripts indicate significant differences between time points in a row 
after transportation (P < 0.05).  
 
 
 
 
 
 
 1 
 
 
 
 
Parameter  
 
 
 
Normal 
Range 
 
 
 
Trt 
Group 
Time, h P-values 
0 24 144  
 
 
Trt 
 
 
 
Time 
 
 
TimeX 
trt 
LS Means ± 
SE 
LS Means       
± SE 
LS Means       
± SE 
 
 
Plasma Protein, g/dL 
 
 
6.9-7.7 
CONT 7.02a ± 0.07 7.40b ± 0.07 7.00a ± 0.07 
 
 
0.32 
 
 
<0.0001 
 
 
0.18 
MEL 7.02a ± 0.07 7.32b ± 0.07 6.88b ± 0.07 
 
 
Total carbon dioxide , mM  
  
CONT 
 
22.77a ± 0.33 24.98b ± 0.34  
 
 
0.51 
 
 
<0.0001 
 
 
0.77 
MEL 22.43a ± 0.33 24.81b ± 0.33  
 
 
Fibrinogen, mg/dL 
 
 
100-500 
CONT 438.11 ± 24.68 462.39 ± 24.68 483.8 ± 25.09 
 
 
0.41 
 
 
0.173 
 
 
0.30 
MEL 426.23 ± 24.30 477.62 ± 24.12 433.85 ± 25.54 
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Table 2. Comparison between the least squares (LS) means ± SE of white blood cell 
parameter data at 0, 24 and 144 h after treatment (trt) with 1 mg/kg meloxicam (MEL) or 
a placebo (CONT) before transportation at 0 h, after transportation at 24 h and at 144 h 
thereafter. 
 
 
a-c Different superscripts indicate significant differences between time points in a row 
after transportation (P < 0.05).  
x,y Different superscripts indicate significant differences between treatment groups in the 
related CONT and MEL columns after transportation (P < 0.05). 
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Table 3. Comparison between the least squares (LS) means ± SE of red blood cell 
parameter data at 0, 24 and 144 h after treatment (trt) with 1 mg/kg meloxicam (MEL) or 
a placebo (CONT) before transportation at 0 h, after transportation at 24 h and at 144 h 
thereafter. 
 
 
a-c Different superscripts indicate significant differences between time points in a row 
after transportation (P < 0.05).  
x,y Different superscripts indicate significant differences between treatment groups in the 
related CONT and MEL columns after transportation (P < 0.05). 
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Table 4. Intercept and slope of chemistry biomarkers and bodyweight change with SE for 
the correlation between meloxicam (MEL) plasma concentration and the outcome 
variables.  
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Table 5. Intercept and slope of hematological biomarkers with SE for the correlation 
between meloxicam (MEL) plasma concentration and the outcome variables. 
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Figure 1. Flow chart outlining the timeline of study events that occurred at time points 0 
h, 24 h and 144 h. Treatment with either meloxicam at 1 mg/kg or a placebo was 
administered at time 0 h after baseline blood sample collection. Follow-up blood 
sample collection for determination of biomarkers and drug concentrations 
occurred after a 16 h (1,316 km) transportation event and 120 h thereafter.  
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 Figure 2.  Mean, ± SE for BW change (kg) after treatment with 1 mg/kg 
meloxicam or a placebo at 0 h followed by a 16 h (1,316 km) transportation event. 
Letters that are the same indicate data points that are not significantly different (P 
< 0.05).  
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 Figure 3.  Mean, ± SE for serum cortisol concentrations after treatment with 1 
mg/kg meloxicam or a placebo at 0 h followed by a 16 h (1,316 km) transportation 
event. Letters that are the same indicate data points that are not significantly 
different (P < 0.05).  
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Figure 4.  Mean, ± SE for plasma log haptoglobin (Hp)-matrix metalloproteinase-9 
(MMP-9) complex concentrations after treatment with 1 mg/kg meloxicam or a 
placebo at 0 h followed by a 16 h (1,316 km) transportation event. Letters that are 
the same indicate data points that are not significantly different (P < 0.05).  
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 Figure 5. Mean, ± SE for serum tumor necrosis factor -alpha (TNF) 
concentrations after treatment with 1 mg/kg meloxicam or a placebo at 0 h 
followed by a 16 h (1,316 km) transportation event. Letters that are the same 
indicate data points that are not significantly different (P < 0.05).  
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 Figure 6.  Mean, ± SE for plasma substance P concentrations after treatment with 
1 mg/kg meloxicam or a placebo at 0 h followed by a 16 h (1,316 km) 
transportation event. Letters that are the same indicate data points that are not 
significantly different (P < 0.05).  
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Figure 7.  Mean, ± SE for circulating neutrophil counts after treatment with 1 
mg/kg meloxicam or a placebo at 0 h followed by a 16 h (1,316 km) transportation 
event. Letters that are the same indicate data points that are not significantly 
different (P < 0.05).  
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Figure 8.  Mean, ± SE for circulating lymphocyte counts after treatment with 1 mg/kg 
meloxicam or a placebo at 0 h followed by a 16 h (1,316 km) transportation event. 
Letters that are the same indicate data points that are not significantly different (P 
< 0.05).  
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Figure 9.  Mean, ± SE for circulating monocyte counts after treatment with 1 mg/kg 
meloxicam or a placebo at 0 h followed by a 16 h (1,316 km) transportation event. 
Letters that are the same indicate data points that are not significantly different (P 
< 0.05).  
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CHAPTER 4.  
IMPACT OF ORAL MELOXICAM AND LONG-DISTANCE TRANSPORT ON 
CELL MEDIATE AND HUMORAL IMMUNE RESPONSES IN FEEDLOT 
STEERS RECEIVING MODIFIED LIVE BVDV BOOSTER VACCINATION AT 
ARRIVAL 
 
Modified from a manuscript published in the journal of Veterinary Immunology and 
Immunopathology 
 
N.K. Van Engen,* R. Platt*, J.A. Roth,* M.L. Stock,† T. Engelken,‡ R.C. Vann,§ L.W. 
Wulf,** W.D. Busby,†† C. Wang,‡‡ E.M. Kalkwarf,** J. F. Coetzee§§ 
 
Abstract 
The objective of this study was to investigate the impact of oral meloxicam 
(MEL) and long-distance transportation on cell-mediated immunity (CMI) in 
preconditioned steers receiving a booster vaccination on arrival. We hypothesized that 
steers treated with MEL at 1 mg/kg body weight, 6 hours before night-time transport, 
would be less immunocompromised on arrival (day 0) and after 7 days, and that CMI 
following vaccination with a modified live bovine viral diarrhea virus (BVDV) recall 
                                               
* Department of Veterinary Microbiology, Iowa State University 
† Biomedical Sciences, Iowa State University 
‡ Veterinary Production Animal Medicine, Iowa State University 
§ Brown Loam Research Branch, Mississippi State University 
** Veterinary Diagnostic Laboratory, Iowa State University 
†† Tri-County Steer Carcass Futurity Cooperative; Tabor, Iowa 
‡‡ Veterinary Production Animal Medicine, Iowa State University 
§§ Anatomy and Physiology, Kansas State University 
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antigen would be increased. Brahman crossbreed steers, 13 to 17 months of age (n=87), 
were randomly assigned to one of four treatment groups: MEL, transported (MTR) 
(n=22), MEL, non-transported (MNT) (n=22), lactose placebo, transported (CTR) 
(n=21), and lactose placebo, non-transported (CNT) (n=22). MTR and CTR steers were 
transported for approximately 16 hours non-stop on a truck from Mississippi to Iowa 
(approximately 1,300 km), whereas steers in the MNT and CNT groups remained in 
Mississippi as non-transported controls. Body weight was measured and jugular blood 
was collected at −1, 0, and 7 days from all steers at the same time, regardless of location. 
Multi-parameter flow cytometry (MP-FCM) was used to identify T-cell subsets and 
detect the expression of three activation markers (CD25 [interleukin (IL)-2 receptor], 
intracellular interferon-gamma (IFNγ), and interleukin-4 (IL-4) after in vitro stimulation 
with BVDV recall antigen. Plasma cortisol concentration was measured on day −1, 0, and 
7 as a marker of transport-associated stress. Serum antibody titer to BVDV was assessed 
on day −1 and day 7 post-booster vaccination. Whole-blood samples were analyzed using 
MP-FCM on days 0 and 7. Results were log transformed and analyzed using repeated 
measures of analysis of variance. Compared with non-transported controls, transport led 
to an increase in BVDV-induced expression of CD25, IFNγ, and IL-4 in CD4+, CD8+, 
and γδ+ T-cell subsets (P<0.05). MEL treatment mitigated the transportation-associated 
increase in CD25 expression by peripheral blood mononuclear cells (PBMCs), CD4+, and 
γδ+ T cells. CMI outputs for the MTR group were less than those of the CTR group 
(P<0.05); however, the MTR and NT groups did not differ (P>0.10). A 
treatment*transport interaction was noted for the increase in IL-4 expression by CD8+ T 
cells after transport, with a significant difference between the CTR and MTR groups at 
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day 7. In conclusion, the use of oral MEL prior to transport appears to have inhibitory or 
homeostatic effects, but further research is needed to validate the effect of MEL treatment 
on specific T-cell subsets in transported cattle. 
Introduction 
Stressful events predispose young calves to bovine respiratory disease (BRD). 
Transportation is one of the most stressful events in the life of a young calf (von Borrell, 
2013; Fike and Spire, 2006; Tarrant 1990). Stress can alter immune function, potentially 
compromising the welfare of the animal by increasing the likelihood that it will develop 
BRD (Buckham Sporer et al., 2008). Most advising veterinarians recommend that 
producers use disease prevention protocols, such as vaccination or antimicrobial 
metaphylaxis, to reduce the likelihood of respiratory problems developing upon arrival 
(Nickell and White, 2010). Vaccination on arrival has been shown to be beneficial in 
promoting a rapid increase in antibody (Ab) titer in response to type 1 strain bovine viral 
diarrhea virus (BVDV) (Richeson, et al., 2009). Viral infections, such as BVDV, have 
been linked to increased risk of secondary bacterial infection in BRD, leading to 
increased morbidity and mortality (Edwards, 2010). BVDV is known to compromise the 
immune system in naïve calves. Diligent use of vaccination practices can decrease the 
incidence of BVDV infection and the subsequent development of BRD (Fulton et al., 
2005).  
 Transport-associated stress increases the levels of pro-inflammatory and stress-
related biomarkers in cattle (Arthington et al., 2003; Cooke et al., 2013). Preemptive 
administration of a long-acting nonsteroidal anti-inflammatory drug (NSAID), such as 
meloxicam (MEL), may reduce the negative impact of transport-associated stress on 
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physiological biomarkers in cattle (Van Engen et al., 2014; Guarnieri Filho et al., 2014). 
MEL has been approved in Europe for use in cattle as an anti-inflammatory drug, and in 
Canada for analgesia at the time of calf disbudding procedures. As alternatives to 
widespread antimicrobial use in food animals are being sought, changes to current 
treatment and management protocols will be needed. These changes could entail 
combinatorial pretreatment with NSAIDs, arrival vaccination, and limited metaphylaxis 
to prevent BRD.  
The objective of the present study was to examine the effect of MEL treatment 
and long-distance transportation on cell-mediated immunity (CMI). CMI responses were 
evaluated in MEL-treated steers 0 and 7 days after vaccination. The CMI responses were 
then compared with those of MEL-treated and untreated steers not subjected to transport. 
Lymphocyte responses to BVDV type II Ag were evaluated using in vitro T-cell 
stimulation and multi-parameter flow cytometry (MP-FCM) analysis using fluorescence-
labeled antibodies. 
 
Materials and methods 
 The Iowa State University animal care and use committee (IACUC) approved all 
procedures described and performed during this study (IACUC# 5-12-7355 B). 
Animals 
A total of 87 uniform Brahman crossbred feedlot steers (353 ± 37 kg; 13 to 17 
months of age; from the Brown Loam Branch Experiment Station, Raymond, 
Mississippi) were used in this study. All steers were free of visual or clinical signs of 
disease, and were vaccinated twice (before and after weaning) against Clostridium spp. 
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(Ultra bac 7, Zoetis, Madison, NJ), MLV BVDV types I and II, parainfluenza-3 virus, 
infectious bovine rhinotracheitis virus, bovine respiratory syncytial virus (Pyramid 5, 
Boehringer Ingelheim, St. Joseph, MO), and Mannheimia haemolytica (One Shot, Zoetis, 
Madison, NJ).  
Study design 
This study was a 2×2 factorial trial that randomly assigned 87 steers into 4 study 
groups: MEL, transported (MTR) (n=22); MEL, non-transported (MNT) (n=22); placebo, 
transported (CTR) (n=21); and placebo, non-transported (CNT) (n=22) (Figure 1).  
Baseline variables included body weight, plasma cortisol concentrations, MEL 
concentrations, and serum Ab titer. Plasma and serum samples for baseline 
determinations were collected on day −1. The MEL-treated groups received MEL 
(Meloxicam tablets, Aurobindo Pharma Limited, Dayton, NJ) administered orally at 1 
mg/kg body weight, whereas the placebo-treated groups received an equivalent weight in 
lactose placebo administered orally, 3 hours before groups MTR and CTR were loaded 
onto the truck. Oral administration was accomplished using a balling gun and a single 
gelatin capsule (Torpac, Fairfield, NJ) containing the entire treatment dose. 
Transportation commenced in the late afternoon, and the animals arrived at the Tri 
County Steer Carcass futurity feed yard, Lewis, Iowa, the following morning, after an 
approximately 16-hour, nonstop trip. Upon arrival (day 0), plasma and whole blood for 
the CMI assays were collected from animals in all groups at approximately the same real 
time at both locations. After sample collection, all animals received a single dose of a 
combined modified live virus vaccine for infectious bovine rhinotracheitis, BVD Types I 
and II, parainfluenza-3, and bovine respiratory syncytial virus (BoviShield 5; Zoetis, 
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Madison, NJ). On day 7, body weight was determined, and plasma, serum and whole 
blood was collected from animals in all groups at both locations at approximately the 
same real time.  
Sample collection 
Blood samples were collected from the jugular vein. Three 10-mL vacutainer 
tubes (BD Vacutainer, Franklin Lakes, NJ; EDTA tubes, lithium heparin tubes, and 
serum separator tubes) were used to collect blood samples to be centrifuged for serum 
and plasma. Whole-blood samples (13.5 mL) were collected in 20-mL plastic syringes 
with 1.5 mL of 2 × acid citrate dextrose (ACD; 0.15 M sodium citrate, 0.076 M citric 
acid monohydrate, 0.287 M dextrose). The needles were removed and the syringes 
capped. These samples were process according to the CMI materials and methods 
section. Blood samples for serum and plasma were processed within 30 min of collection 
by centrifugation at 1,600 × g for 15 min. The serum and plasma were immediately 
frozen on dry ice and stored at −80°C until tested. On days 0 and 7, the whole blood 
collected from animals in the MNT and CNT groups was transported overnight at room 
temperature (22°C) to Ames, Iowa by the study investigators, whereas whole blood 
collected from animals in the MTR and CTR groups in Iowa was transported to the 
laboratory and held in the laboratory at room temperature (22°C) for the same duration. 
All whole-blood samples were submitted for the CMI assay and tested at the same time. 
Weights were determined using scales on site at the Brown Loam research facility 
and at Tri County Steer Carcass futurity feed yard. Scales were certified and calibrated at 
each site using standardized test weights. Furthermore, researchers collecting the data 
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verified that the scale was in proper working condition prior to data collection using test 
weights.  
Cortisol analysis 
Plasma cortisol was determined using a commercially available Coat-a-Count 
radioimmunoassay kit (Siemens, Malvern, PA), as previously described by Van Engen et 
al. (2014). Briefly, 125iodinated cortisol was used in the analysis procedure to determine 
its concentration using a gamma counter. As described in the manufacturer’s instructions, 
25 l of plasma was added to each polypropylene tube containing Abs immobilized 
within the tube wall. One milliliter of 125iodinated cortisol stock solution was added, 
incubated for 45 minutes at 37°C, and decanted.  The standard curve provided by the 
manufacturer had an r2 value >0.98, the assay’s detection range was 3 to 500 ng/mL, and 
the inter- and intra-assay variability was 13% and 11.5%, respectively. 
MEL concentration analysis 
The plasma concentration of MEL was determined using high-pressure liquid 
chromatography (Surveyor MS Pump and Autosampler; Thermo Scientific, San Jose, 
CA) with mass spectrometry detection (TSQ Quantum Discovery MAX; Thermo 
Scientific). A 100-μL volume of 1 M trichloroacetic acid was added to 200 μL of each 
sample of plasma, spiked plasma, and quality control plasma, following the addition of 
piroxicam (10 μL of a 10 ng/μL stock) as an internal standard. The samples were 
vortexed for 5 s and then centrifuged for 20 min at 2,000 × g to sediment the precipitated 
material. A 150-μL portion of the supernatant was transferred to an injection vial fitted 
with a glass insert containing 100 μL of 1.9% ammonium hydroxide in 25% aqueous 
acetonitrile. The injection volume was set to 12.5 μL. Mobile phase A consisted of 0.1% 
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formic acid in water, and mobile phase B consisted of 0.1% formic acid in acetonitrile. 
The flow rate was 0.250 mL/min. The mobile phase began at 40% B, and samples were 
eluted with a linear gradient to 95% B over 5 min; the composition was maintained at 
95% B for 1.5 min, and then the column was re-equilibrated with 40% B. Separation was 
achieved with a solid-core C18 column (KinetexXB-C18, 100 mm × 2.1 mm, 2.6-µm 
particle size, Phenomenex, Torrance, CA) maintained at 40°C. Piroxicam eluted at 3.3 
min, and MEL eluted at 4.5 min. Four meloxicam and three piroxicam transitions were 
monitored during mass spectrometry analysis via selected reaction monitoring mode. The 
quantifying ions were 72.99, 88.01, 114.99, and 140.98 m/z for MEL and 77.97, 94.98, 
and 120.98 m/z for piroxicam. Plasma blanks, calibration spikes, QC samples, and bovine 
plasma samples were batch processed using a method developed in the Xcalibur software 
(Thermo Scientific, Waltham, MA). The processing method automatically identified and 
integrated each peak in each sample and calculated the calibration curve based on a 
weighted (1/X) linear fit. The concentration of MEL in the experimental plasma samples 
was calculated by the Xcalibur software based on the calibration curve. Results were then 
viewed using the Quan Browser feature of the Xcalibur software. A total of 12 calibration 
spikes were prepared in bovine plasma, covering a concentration range of 5 to 20,000 
ng/mL. QC samples were prepared at concentrations of 15, 150, and 1,500 ng/mL. QC 
samples were prepared in duplicate with each set of samples. Calibration curves exhibited 
a correlation coefficient (r2) exceeding 0.998 across the entire concentration range. The 
QC samples at 150 and 1,500 ng/mL were within 2–9% of their nominal values. The low 
QC at 15 ng/mL differed from its nominal value by 13–15%. 
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Serum virus neutralization test 
Sera from each sample were submitted to the Veterinary Diagnostic Laboratory at 
the College of Veterinary Medicine at Iowa State University. The serum virus 
neutralization tests for BVDV type II virus used the 125 genotype 2 strain as antigen 
(Ag).  
CMI assay 
Whole-blood samples were transferred from capped syringes to 15-mL centrifuge 
tubes and then centrifuged at 1,000 × g for 20 min. The buffy coats were collected, red 
blood cells were lysed and peripheral blood mononuclear cells (PBMCs) were pelleted, 
isolated and washed as previously described (Platt et al., 2008). MP-FCM was performed 
to assess the memory response of T-cell subsets to BVDV type II. A 200-µL aliquot of 
each PBMC suspension, containing 106 cells, was added to each of the four wells of a 96-
well flat-bottomed tissue culture microtiter plate. Two wells received 50 µL of RPMI++ 
(RPMI containing 15% fetal bovine serum and 1.5% penicillin/streptomycin solution) as 
non-Ag-stimulated controls. The other two wells received 50 μL of a suspension of 
BVDV type II (Strain 890, 4.2×106 TCID50/mL, propagated in MDBK cells; Ridpath, J., 
National Animal Disease Center, Ames, IA). The plates were incubated at 37°C in a 
humidified 5% CO2 incubator. On day 4 of the incubation, PBMCs in all wells were 
stained and analyzed by MP-FCM, and the results were analyzed as described earlier 
(Platt et al., 2009). 
Statistical analysis 
SAS software (version 9.2, SAS Institute, Inc., Cary, NC) was used for statistical 
analyses. Repeated measures analysis of variance was used to compare the main effects 
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of meloxicam administration and of transportation over time, and their respective 
interactions.  Statistical significance was designated as a P value <0.05. Cellular 
responses were evaluated using an expression index (EI), as defined by the equation 
shown in Figure 2. The EI numerator refers to cells stimulated with BVDV recall Ag, and 
‘unstimulated’ refers to cells from the same animal not exposed to the BVDV recall Ag. 
The EI for each treatment group was analyzed as the response variable, assuming a 
Gaussian distribution. This method was used for all parameters investigated in this study. 
Variables that did not exhibit normal distribution were log transformed.  
Results 
Plasma MEL concentration 
 Prior to treatment (at day −1), no steers had detectable concentrations of MEL in 
plasma. On day 0, the plasma MEL concentration ranged from 1.39 to 3.72 μg/mL, with a 
mean (±SD) of 2.79 (±0.55) μg/mL. On day 7, the concentration ranged from 0.00 to 0.20 
μg/mL, with a mean (±SD) of 0.02 (±0.03) μg/mL. All steers in both the TR and NT 
groups that were designated to receive MEL tested positive for the drug, and all controls 
tested negative.  
Change in body weight  
The weight of all steers was monitored throughout the study and changed 
significantly as a result of interactions between time and transport (P<0.0001). However, 
the effect of MEL treatment alone was not significant (P=0.667). The weight of steers in 
both the MTR and CTR groups had decreased on day 0, upon arrival following transport. 
No significant change in weight was observed in steers not subjected to transport. By day 
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7, the transported steers had recovered their lost weight and showed an additional weight 
increase as a group (Figure 3). 
Cortisol concentration 
A time*transport interaction (P=0.036) was noted with respect to cortisol 
concentration, with an observed increase on day 0 in TR steers; however, neither 
transportation alone (P=0.119) or MEL administration alone had an impact on plasma 
cortisol concentrations (P=0.340). 
Titer of BVDV-neutralizing antibodies   
The Ab titer results for both the TR and NT groups for both MEL and CONT 
animals combined were log2 transformed (Figure 4). The titer increased over time in both 
groups between day −1 and day 7 (P<0.001). No effects associated with transport 
(P=0.600) or treatment were observed (P=0.645).  
CMI responses 
Three different cell types were analyzed to assess the effects of TR and MEL on 
CMI, namely CD4+ T cells, CD8+ T cells, and γδ+ T cells. Data are also shown for total 
PBMCs without differentiation of the cell type. Furthermore, three expression indices 
were calculated for each cell type namely, CD25, interferon-gamma (IFNγ), and 
interleukin (IL)-4.  
A time effect was observed for all groups of cells (P<0.001), except in the case of 
PBMCs expressing CD25 and γδ+ T cells expressing IFNγ (P>0.05). In terms of the main 
effects, the primary outcome of this research trial was evidence of an increase in overall 
peripheral blood CMI responses (P<0.05) following transportation (Table 1). 
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Furthermore, a main effect of meloxicam treatment was observed, as evidenced by 
changes in CD25 expression on PBMCs, CD4+, and γδ+ T cells (Table 1). Specifically, 
CMI outputs in the MTR group were lower than in the CTR group but similar to the NT 
groups. In addition, a treatment*transport interaction was noted with respect to IL-4 
expression in CD8+ T cells. Specifically, expression increased after transport, with a 
difference observed between the CTR and MTR groups on day 7. The individual 
significance of these effects is highlighted in Table 1.  
PBMCs 
There was evidence of a time*transport interaction in the expression of CD25 on 
PBMCs (P=0.051) (Table 1). Specifically, CD25 expression on PBMCs in the CTR 
group was significantly elevated on day 7 compared with all other groups (P<0.05) 
(Figure 5). PBMC expression of IFNγ also supported a time*transport interaction 
(P=0.047) (Table 1). Instead, PBMC IFNγ expression in the MTR group was elevated 
compared with the MNT group at 7 days after the administration of the MLV BVDV 
(P=0.045). A significant effect of transport was also noted for IL-4 expression by PBMCs 
was higher in the CTR group compared with the CNT group (P=0.047) on day 0.  
CD4+ T cells 
Transport was associated with a significant increase in CD25 expression on CD4+ 
T cells in the CTR group compared with the MNT group on day 7 (P=0.005) (Figure 6). 
Furthermore, there was a time*transport interaction for mean IFNγ EI (P=0.0024) and 
IL4 (P=0.007) expression in CD4+ T cells (Table 1). A transport*time interaction was 
also evident for IL-4 expression, as indicated by differences on day 0 between the CTR 
and MNT groups (P=0.007). Specifically, the expression of IL-4 in the CTR group was 
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increased on arrival in comparison with that in the MNT group (P=0.010). No differences 
in IL-4 expression were observed between groups on day 7. 
CD8+ T cells 
Transport affected the expression of CD25 on CD8+ T cells on day 7 following 
arrival and administration of the MLV BVDV vaccine. Specifically, CD25 expression at 
day 7 was higher in the CTR group than in all other groups (P<0.05) (Figure 7). No 
difference in CD25 expression was observed among groups at arrival on day 0. IFNγ 
expression by cytotoxic T cells was elevated in the CTR group compared with the MNT 
group on day 7 (P=0.0095). Overall there was a time*transport interaction for IL-4 
expression (P=0.0237). Within the CD8+ T-cell population, the expression of IL-4 on day 
7 mimicked the trend in the expression of IFNγ on CD8+ T cells. Expression of IL-4 by 
CD8+ T cells in the CTR group was increased in comparison with the other 3 groups at 
day 7 (P<0.05) (Figure 8).  
γδ+ T cells 
A time*transport interaction was observed in the expression of CD25 on γδ+ T 
cells (P=0.0486). Specifically, CD25 expression on γδ+ T cells was elevated on day 7 in 
the CTR group compared with all other groups (P<0.05) (Figure 9). No differences were 
observed in CD25 expression on γδ+ T cells on day 0 between groups. Similarly, there 
was no difference in the expression of IFNγ by γδ+ T cells on day 0 or day 7; however, a 
time*transport interaction was observed (P=0.0087). Specifically, IL-4 expression 
increased in the CTR group compared with the MNT group (P=0.049). No other 
significant differences were observed in IL-4 expression by γδ+ T cells between groups. 
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Discussion 
 Assessing stress in cattle by visual inspection can be challenging. In this study, 
we examined the impact of TR, MEL, and their interaction on different aspects of the 
immune system over time. To our knowledge, no studies examining the effects of MEL 
administration on CMI prior to long-distance transport of cattle, or their corresponding 
CMI responses following arrival and administration of MLV BVDV have been reported. 
Manipulation of immune responses through vaccination is a common practice that has 
shown great value in preventing disease. We hypothesized that the concurrent 
administration of meloxicam would impact the host immune response at the time of 
vaccination and enhance the vaccine response. We found that the use of oral MEL prior 
to transport appears to have inhibitory or homeostatic effects on at least one EI for each 
immune cell reported, and has no effect on antibody titer response to MLV BVD at day 7. 
The in vivo effects of MEL on immune function in cattle are poorly understood; evidence 
from studies in mice suggests that MEL administration following vaccination in order to 
reduce the pain associated with an adjuvant does not interfere with the immune response 
(Kolstad et al., 2012).  
Pharmacologically, MEL reaches its highest concentration (i.e., Cmax) in cattle 12 
h after administration, with a plasma half-life of 28 h (Coetzee et al., 2009). Therefore, in 
the present study, MEL concentration is presumed to have peaked during transport; 
therefore, six plasma elimination half-lives would have transpired by day 7. The mean 
plasma Cmax of 3.10 μg/mL (range 2.64–3.79 μg/mL) is reported and a median effective 
concentration for meloxicam in the plasma, applied from a lameness study in horses, is 
approximately 0.2 μg/mL (Coetzee et al., 2013). Although the drug concentration is low 
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on day 7, the pharmacokinetics of the anti-inflammatory effects of the NSAID suggests 
long lasting therapeutic drug concentrations for part of the week and during this time the 
body is responding to the immunization on day 0. MEL is not specifically approved for 
use in cattle in the United States; however, extra-label use is allowed under the Animal 
Medicinal Drug Use Clarification Act (United States Food and Drug Administration, 
2014) for analgesia, because there are currently no compounds specifically approved for 
this purpose. 
Weight loss is an unavoidable consequence of long-distance transportation of 
cattle. We hypothesized that weight loss would be evident in animals in the TR groups, 
whereas the weight of cattle in the NT groups would remain relatively constant. Our 
results indicate that this hypothesis was correct and consistent with results reported 
elsewhere (Cooke et al., 2013). Body weight declined following transportation in our 
study, and MEL treatment had no effect on weight loss or resumption of weight gain 
upon arrival at the feed yard. In cattle, weight loss is greatest within the first 12 h during 
transportation, and the greatest losses are typically seen in cattle that are fed roughage 
diets versus concentrates (Knowles, 1999). These results are typical of any production 
scenario and are unaffected by MEL treatment. However, one research group recently 
reported that oral MEL administration is beneficial in preventing a decrease in dry-matter 
intake 1 week following transportation, and in preventing an overall decline in 
performance following transportation (Guarnieri Filho et al., 2014). These conflicting 
results may have been due to differences in study design, specifically the breed, age, 
duration of the transportation event, and sampling times over the course of the study. 
Differences in diet composition at the different locations in which the present study was 
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conducted may have had an impact on the differences in performance observed on day 7. 
However, most changes were probably due to increased rumen feed content. 
Based on previous research, we hypothesized that steers in the TR groups would 
have significantly higher plasma cortisol concentrations than those in the NT groups 
(Knowles et al., 1997; Murata et al., 1987; Buckham Sporer et al., 2008). The effect of 
time*transportation interaction reported herein support this hypothesis. However, 
determining the difference between the two main effects is challenging because this 
interaction was likely due to the lack of a transportation event on day -1. We also 
hypothesized that MEL-treated steers would have lower plasma cortisol concentrations 
than their CONT counterparts in both the TR and NT groups. However, no differences 
were observed at any time between the MEL-treated and CONT groups. There are many 
potential confounders that could trigger adrenocorticotropic hormone production and 
subsequent cortisol release during transportation. Our finding of an increase in cortisol 
levels associated with transportation agrees with many reports in the literature, but 
contradicts our previous findings (Van Engen et al., 2014). Previously, we found that 
relative to baseline, cortisol concentrations decrease in plasma after TR. Our previous 
experiments may have been influenced by stress resulting from limited handling events, 
whereas the steers used in the current study may have been better acclimatized to 
processing, and the NT groups were comparable.  Increased cortisol concentrations can 
have numerous implications, but in the present study, we interpreted increased cortisol as 
a stress marker and indicator of potential negative immunological effects. 
Glucocorticoids may suppress the immune system (Roth and Kaberle, 1982). Using 
human gene profiling, Gallon et al. (2002) concluded that glucocorticoids can upregulate 
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the innate immune system and inhibit the adaptive immune system. At day 0, the TR 
group had no statistically significant difference in cortisol levels compared to the NT 
group. The limited sampling points may have missed changes in endogenous 
glucocorticoid levels that could have effected immunological CMI patterns.  Further 
research is needed to evaluate the effect of MEL treatment on specific T-cell subsets in 
transported cattle that have significantly higher cortisol in comparison with a control 
population. 
 We hypothesized that an increase in the expression of CMI markers (e.g., CD25, 
IFNγ, and IL-4) would be observed in the TR groups compared with the NT groups, but 
that immune function in MEL-treated calves would be maintained due to the use of 
NSAIDs, which would reduce changes in physiological biomarkers that are associated 
with the stress of transportation (Van Engen et al., 2014; Cooke et al., 2013). Our results 
suggest that the expression of CD25 and IL4 was lower in the MTR group compared with 
the CTR group, particularly at day 7. EI in the MTR was equivalent to that in both the 
MNT and CNT groups (Figures 7 and 10). These results appear to support our hypothesis 
that MEL would maintain immune function at a level similar to that of the NT controls. 
However, because shipping resulted in a higher expression of CMI markers in TR steers 
compared with NT steers on arrival and at 7 days post-arrival (Figure 5 and Figure 7), an 
alternate interpretation of the data could be that MEL reduced the overall CMI response, 
resulting in there being no difference between MEL and NT calves on Day 7.  Further 
studies to delineate these outcomes are warranted.  
In the present study, we were able to look at the effects of transport and 
meloxicam on cellular memory. Expression of CD25 on CD4+ T cells are interpreted as a 
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marker of a memory response.  In evaluating the memory response at day 0 and day 7 
using the expression index, the equation takes into account CD4+ cells that constitutively 
express CD25 and are understood to be T regulatory (Treg: CD4
+CD25+) cells (Seo et al., 
2007). The cells are evaluated in the denominator of the EI and are compared to 
stimulated CD4 cells expressing CD25 in the numerator of the equation (Figure 2). Thus, 
the CD4+CD25+ cell EI was considered a marker of the memory response toward BVDV 
in this study. The memory response was higher in the CTR group (day 0), and MEL had 
no effect on this cell population between individual treatment groups. However, on day 7, 
there was a significant difference between the MNT and CTR groups (Figure 6).  A study 
examining the effects of MEL exposure on the proliferation of CD4+ T cells in vitro 
demonstrated an increase in CD4+CD25+ T cells (Maslanka and Jaroszewski, 2012). 
These results, combined with our findings, support the hypothesis that MEL does not 
inhibit immune responses in transported animals upon arrival. Conversely, the treatment 
effect observed at day 7 is notable: after a full week of exposure to the anti-inflammatory 
effects of MEL, the level of CD25 expression in the MTR group was comparable to that 
of the NT group. This observation supports the conclusion that MEL administration 
decreases the CMI response at day 7.  
CD25 expression on γδ+ T cells was similar in the NT and MTR groups, but 
greater in the CTR animals relative to the other groups.  Bovine γδ+ T cells have multiple 
immune functions and play innate, adaptive, and regulatory roles (Guzman et al., 2011). 
In human, murine, and bovine models, cells that constitutively express CD4+CD25+ are 
considered Treg cells, which can exert immunosuppressive effects. However, Hoek et al. 
(2008) reported that the γδ+ T cell subpopulation expressing FoxP3 may not exert similar 
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effects in cattle, whereas other γδ+ T-cell subsets in cattle do suppress the immune 
system. Given that CD25 expression may not necessarily be an indicator of regulatory 
function for γδ T cells in cattle, and our analysis did not distinguish between γδ+ T-cell 
subsets, more research is needed to identify which specific subsets were impacted by 
MEL administration prior to transportation, so that the overall effect on the immune 
system can be elucidated.  
Contrary to our hypothesis that IFNγ expression would be lower in TR steers on 
day 0 compared with NT or MEL-treated steers, none of the T-cell subsets exhibited a 
decrease in IFNγ associated with TR or treatment. However, there was an increase in 
IFNγ production by PBMCs in CTR animals compared with CNT animals upon arrival, 
suggesting that TR causes an increase in IFNγ expression. This conflicts with results 
reported by Gupta et al. (2007), who found a significant increase in cortisol levels and 
reduction in IFNγ production by cultured lymphocytes in Holstein-Friesian bulls after a 
12-h transport event. This disparity is likely associated with differences in the age, sex, 
and breed of the animals used in these two studies. IFNγ expression is important in Ag-
specific memory responses, and is necessary for T helper 1 responses to viruses (Platt et 
al., 2008). The T helper 1 response is key for both the stimulation of Ab production and 
the recall response to BVDV. We also found that MEL had no significant effect on IFNγ 
expression, a finding that is in agreement with those reported by Maslanka et al. (2012), 
who described the effects of MEL on CD8+ lymphocytes in vitro. Overall, their findings 
suggested that in contrast to dexamethasone, which exhibits immunosuppressive effects, 
MEL is safe for use in treating infection-associated inflammation in veterinary practice. 
Bednarek et al. (2003) suggested that the inhibition of cyclooxygenase-2 has multiple 
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effects mediated through inhibition of prostanoids, potentially resulting in the 
normalization of tumor necrosis factor-alpha levels and increased production of IFNγ in 
lung bronchial alveolar macrophages. The absence of this effect in the present study may 
be because we studied immune cells outside the lungs that may react differently 
following stress, such as that associated with long-distance transport.  
IL-4 causes the differentiation of naïve T helper cells into T helper 2 cells, which 
play a pivotal role in the development of humoral responses to Ag through the 
stimulation of B cells (Estes et al., 1995). As previously mentioned, the stress associated 
with TR led us to hypothesize that IL-4 expression by all cell populations would be lower 
in the TR group compared with the NT group. The interaction between MEL and TR on 
IL-4 expression was unexpected, and renders it difficult to differentiate the two main 
effects for circulating CD8+ cells. The significant increase in IL-4 expression in the CTR 
group compared with all other groups on day 7 suggests that MEL may assist in the 
maintenance of normal IL-4 expression by circulating CD8+ T cells after transport. The 
MTR EI was similar to that of both the MNT and CNT groups; however, based on our 
sampling time points, it is difficult to draw inferences regarding the kinetics of IL-4 
expression by CD8+ cells and the potential effects this may have on humoral responses 
through T-cell regulation.   
Overall, transportation can cause significant changes in immune function in cattle. 
Though this is the initial interpretation of our results, drawing inferences regarding the 
kinetics of T-cell populations is both difficult and risky. Within the first week after 
vaccination, T cells migrate to the lymphoid tissue to undergo clonal expansion in 
response to the vaccine Ag (Murphy et al., 2012). Thus, to extrapolate a response based 
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on measurements made on days 0 and 7 would be difficult, because we examined blood 
lymphocytes, and it would take much longer to detect humoral indications of clonal 
expansion. Other factors, such as the breed, age, or sex of the animals may influence the 
effect of stress. These factors make it difficult to ascribe a causal relationship, but our 
results do provide a basis for directing further investigations of the effects of 
transportation stress and the observation that MEL either does or does not influence 
immune function.  
We initially hypothesized that there would be an increase in BVDV Ab titer due 
to the recall response, irrespective of treatment with MEL. Sampling 7 days after 
vaccination represents a rapid turnaround for Ab-response examination and thus makes 
interpretation difficult. However, in this case, the log2-transformed Ab-response data 
suggest that neither MEL, nor transportation-induced stress, had an immediate effect on 
vaccination recall response. Richeson et al. (2009) examined the effect of vaccine 
administration immediately following transportation, and reported that anti-BVDV type I 
Ab reached a high titer sooner than animals vaccinated after 14 days, without 
compromising average daily weight gain or growth. Other investigations also confirm our 
findings that MEL did not affect vaccination response to respiratory pathogens 
(Rodrigues et al., 2015). 
Conclusions 
In conclusion, long-distance transportation affects both physiological 
homeostasis, and impacts CMI in beef steers. No differences in CMI were observed in the 
present study between MNT and CNT steers, however, some effects associated with the 
stress of transportation were observed and are not yet fully understood. Our study 
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provides evidence that the early increase in Ab titer to BVDV in response to vaccination 
is not affected by MEL or transportation.  Changes in the CMI response demonstrated 
effects due to transportation and treatment with MEL. The results of this study indicate 
that CMI responses in the MTR were equivalent to those in NT for most outcomes, and 
that CMI responses were elevated in the CTR group compared to the other groups. These 
two outcomes suggest that MEL either has an inhibitory effect on CMI when transported 
or has a homeostatic effect when compared to NT controls. Further investigation is 
necessary to assess if there is an effect on disease outcome on arrival in cattle at high risk 
for BRD. 
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Table 1. Mean (±SEM) expression indices for various immune cells: PBMCs, CD4+ T cells, CD8+ T cells, and γδ+ T cells. 
Expression index was defined as: [the percent of cells expressing the indicated marker after stimulation with BVDV Ag 
multiplied by the mean MP-FCM fluorescence intensity], divided by [the percent of unstimulated cells expressing the indicated 
marker multiplied by the mean MP-FCM fluorescence intensity]. Cell markers of interest were CD25, IFNγ, and IL-4. 
Sampling occurred on days 0 and 7. Each primary group (transported and non-transported) consisted of meloxicam (MEL)-
treated (1 mg/kg) and untreated (CONT) calves.  Groups with a single superscript (a, b) indicates a significant difference 
(P<0.05). Each superscript letters are for comparison within each row. NS indicates the difference was not significant 
(P>0.05).  
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Figure 1. Flow chart outlining the study timeline. Calves in the transport and non-
transport groups were administered either 1 mg/kg meloxicam (MEL) or a placebo 
(CONT) orally on day −1, after baseline blood sample collection. Follow-up blood 
sample collection for determination of biomarkers, drug concentrations, and CMI 
data occurred after a 16-h (1,316 km) transport event (day 0) and 7 days later. 
Modified live vaccine administration occurred after blood sampling on day 0. 
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Figure 2. Equation for calculating the expression index using flow cytometry data. 
“Stimulated” refers to cells stimulated with BVDV recall antigen, and 
“unstimulated” refers to a sample of cells from the same animal that were not 
stimulated with BVDV recall antigen. The percentage of both stimulated and 
unstimulated positive cells was multiplied by the corresponding geometric mean 
fluorescence intensity. 
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Figure 3. Mean (±SEM) body weight (kg) after treatment with 1 mg/kg meloxicam 
(MEL) or a placebo (CONT) on day −1, followed by either a 16-h (1,316 km) 
transport event (TR) or non-transportation (NT). Comparisons were made across 
time and between transport groups. Different letters indicate statistically 
significant differences (P<0.05). Interaction between time and transport 
(P<0.0001) is present however, the effect of MEL treatment alone was not 
significant (P=0.667). 
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Figure 4. Mean (±SEM) log2-transformed type 2 BVDV antibody concentration. MLV to 
BVDV was administered on arrival at day 0, after sample collection. Comparisons 
were made across time and between groups (MTR, CTR, MNT, CNT). Different 
letters indicate a significant difference (P<0.05).  Time was the only main effect of 
significance, and titer increased for both groups between day −1 and day 7 
(P<0.001). 
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Figure 5. Mean (±SEM) index of CD25 expression on PBMCs. The expression index is 
defined as the percentage of cells expressing CD25 after stimulation with BVDV 
Ag divided by the percentage of unstimulated cells expressing CD25. The 
percentage of positive cells in both the numerator and denominator was multiplied 
by the mean flow cytometry fluorescence intensity. Different letters indicate a 
significant difference (P<0.05). Test slices were separated by day and significance 
based on treatment (P=0.0019) and transport (P=0.0231) main effects. 
Comparisons were made between individual treatment groups (MTR, CTR, MNT, 
CNT). 
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Figure 6. Mean (±SEM) index of CD25 expression on CD4+ T cells. The expression 
index is defined as the percentage of cells expressing CD25 after stimulation with 
BVDV Ag divided by the percentage of unstimulated cells expressing CD25. The 
percentage of positive cells in both the numerator and denominator was multiplied 
by the mean flow cytometry fluorescence intensity. Different letters indicate a 
significant difference (P<0.05). Test slices were analyzed by day and significance 
was interpreted based on the treatment (P=0.0433) and transport (P=0.0007) main 
effects. Comparisons were made between individual treatment groups (MTR, 
CTR, MNT, CNT). 
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Figure 7. Mean (±SEM) index of CD25 expression on CD8+ T cells. The expression 
index was defined as the percentage of cells expressing CD25 after stimulation 
with BVDV Ag divided by the percentage of unstimulated cells expressing CD25. 
The percentage of positive cells in both the numerator and denominator was 
multiplied by the mean flow cytometry fluorescence intensity. Different letters 
indicate a significant difference (P<0.05). Test slices were analyzed by day and 
significance was interpreted based on a transport effect (P=0.0231). Comparisons 
were made between individual treatment groups (MTR, CTR, MNT, CNT). 
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Figure 8. Mean (±SEM) index of IL-4 expression in CD8+ T cells. The expression index 
was defined as the percentage of CD8+ T cells expressing IL-4 after stimulation 
with BVDV Ag divided by the percentage of unstimulated CD8+ T cells 
expressing IL-4. The percentage of positive cells in both the numerator and 
denominator was multiplied by the mean flow cytometry fluorescence intensity. 
Different letters indicate a significant difference (P<0.05). Test slices were 
analyzed by day and significance was interpreted based treatment*transport 
interaction (P= 0.0237). Comparisons were made between individual treatment 
groups (MTR, CTR, MNT, CNT). 
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Figure 9. Mean (±SEM) index of CD25 expression on γδ+ T cells. The expression index 
was defined as the percentage of γδ+ T cells expressing CD25 after stimulation 
with BVDV recall Ag divided by the percentage of unstimulated γδ+ T cells 
expressing CD25. The percentage of positive cells in both the numerator and 
denominator was multiplied by the mean flow cytometry fluorescence intensity. 
Different letters indicate a significant difference (P<0.05). Test slices were 
analyzed by day and significance was interpreted based treatment (P=0.0052) and 
transport (P=0.0056) main effects. Comparisons were made between individual 
treatment groups (MTR, CTR, MNT, CNT). 
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CHAPTER 5. 
THE EFFECT OF PRE-TRANSPORTATION OR ARRIVAL 
MELOXICAM ADMINISTRATION TO CALVES ENTERING THE FEEDYARD 
ON MORBIDITY, BIOMARKERS AND CARCASS CHARACTERISTICS  
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biomarker outcomes associated with BRD, change performance over the first 42 days on 
feed, and influence carcass characteristics at harvest.  
Animals: Multi-sourced, crossbred steer calves (n= 168), consisting of mainly British 
and British-Continental breeds, were purchased from a sale barn in central Kansas.   
Procedures: Calves were processed prior to transportation and again on arrival. Subjects 
were randomized to three separate treatments: pre-transport meloxicam (PMEL), arrival 
meloxicam (AMEL), and a control group receiving inactive excipient (CONT). Animals 
were weighed and blood was collected pre-and post-transport. Haptoglobin (HP)-Matrix 
Metalloproteinase (MMP)-9, Cortisol, and Substance P were quantified. Nasal swabs 
were collected to assess total protein and Annexin A1. Weights were taken again at 42 
days and at harvest. BRD was monitored using the depression, appetite, respiration and 
temperature system (DART). Harvest parameters were collected at the plant using a 
standardized grading system 
Results: Meloxicam did not have an effect on BRD morbidity over the course of the 
study and there was no effect on performance at 42 days (P>0.10). Of the calves that did 
succumb to BRD, no differences were seen in severity of disease (P>0.10). Substance P, 
HP- MMP9, total protein and annexin A1 levels were increased on arrival (P ≤ 0.05) and 
no treatment effect or interaction was noted in the statistical model (P>0.10).   
Conclusions and Clinical relevance: 
Meloxicam administration to steer calves prior to or on arrival as a prophylactic treatment 
does not mitigate BRD, or the severity of BRD for incoming calves and does not aid in a 
performance benefit at 42 days or over the entire feeding period.   
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Abbreviations:  
ADG, average daily gain;  
BRD, bovine respiratory disease;  
BW, body weight;  
DMI, dry matter intake;  
G:F, gain to feed;  
HCW, hot carcass weight;  
HP, haptoglobin;  
MMP, matrix-metalloproteinase;  
NSAID, non-steroidal anti-inflammatory drug;  
QG, quality grade;  
YG, yield grade; 
Introduction 
 Cattle transported long distances, at a lighter BW, are at a greater risk of 
morbidity and subsequent mortality due to bovine respiratory disease. 1  In combination 
these two parameters are a means of classifying cattle into a “high risk” category of 
developing BRD.  Cattle at high risk for BRD are less adept at handling stressors of 
transportation resulting in a decreased immune function. 2  Physical and psychological 
stress over the length of transportation results in changes of circulating physiologic 
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parameters. Specifically, markers of interest that have been connected to inflammation 
and BRD. Glucocorticoids and their endogenous effects on annexin A1 have been 
implicated as a marker of BRD. 3  In addition, acute phase proteins are also suggestive as 
important post transportation markers for the transportation stress. 4 5  Furthermore 
investigation these markers to disease and the effects of therapeutics on these markers is 
warranted and necessary.  
Previous reports have suggested a benefit of reduced lung consolidation when 
nonsteroidal anti-inflammatory drugs (NSAIDs) are administered as an adjunct to 
antibiotics. 6 European legislation requiring the reduction of antibiotics has incited 
research for early intervention with NSAIDs to reduce the use of antibiotics and have 
reported success. 7  Recent investigation directed at the use of NSAIDs in cattle prior to 
transportation focused on performance, and physiologic outcomes.8-10 Flunixin 
meglumine, a labeled antipyretic in cattle, was proven ineffective as a potential drug for 
increased performance on arrival.11 However, use of an alternative NSAID, meloxicam, 
prior to transportation has seen benefit in performance during the first week of arrival. 8  
In addition meloxicam has reduced the transport associated acute phase protein responses 
and reduced the stress leukogram response. 8,9 No investigation has focused on the use of 
NSAIDs in high risk cattle administered prior to transportation to evaluate the effects on 
disease outcomes or performance past 21 days of the feeding period.  We hypothesized 
that treatment with meloxicam prior to or on arrival after transportation would result in 
reduction of disease and increased performance in the first 42 days of the feeding period. 
In addition, we also hypothesized that the initial positive treatment effects would translate 
to improved carcass characteristics at harvest.  
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Materials and Methods 
Before the initiation of this experiment, all animal use, handling, and sampling 
techniques described were approved by the Oklahoma State University IACUC (# AG-
16-1). 
Animals  
Crossbred steer calves (n= 168) consisting of mainly British and British-Continental 
breeds were assembled in Kansas. In two separate events one week apart, an order buyer 
purchased calves deemed high risk from the Kingsville livestock market with initial BWs 
averaging 251 ± 24 kg. Animals were acquired from multiple sources and comingled with 
in the holding facility of the sale barn for an undetermined amount of time. Prior to 
enrollment calves were visually appraised and deemed healthy. During enrollment, 
duplicate ear tags with individual identification were assigned and placed in both ears and 
research data/samples were collected. The animals were loaded on a road transportation 
semi rig on August 11th and 18th 2016. Two truckloads of 89 and 79 calves respective to 
each mentioned day. Pen assignments were randomized and consisted of calves that came 
in on their study day and were from the same treatment group. No mixing occurred to 
account for behavior disruptions. Distance traveled from the livestock market to the 
research feedlot was 533 km. After arrival at the yard the calves were allowed to rest for 
18 hours and then processed for sample collection. 
Study Design 
A randomized complete block design with three parallel arms was adopted for the clinical 
trial. Calves were randomized for treatment at the sale barn according to individual 
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identification in the ear tag. Treatment groups consisted of a pre-transportation 
meloxicam (n= 62) with on arrival placebo (PMEL), pre-transportation placebo (n=53) 
with on arrival meloxicam (AMEL), and controls (n=53) that received placebo both pre-
transportation and on arrival.  Meloxicama (255 mg) dosing per os (PO) was calculated 
based on the estimated weight average of 255 kg to one mg per kg of BW. During 
processing and enrollment at the sale barn, BW, nasal swabs, and blood were collected. 
Bolus administration then occurred with appropriate treatments and verification of 
swallowing was confirmed before release. 
 Cattle were restrained in a processing chute with a rope halter; blood was 
acquired via jugular venipuncture into vacutainer tubes. Processing occurred on site in 
the sale barn. Centrifugation of blood was performed at 3,000 g for 15 minutes. Plasma or 
serum was immediately drawn off of the centrifuged vacutainer tube with a micropipette 
and transferred to a micro-centrifuge tubes in duplicate. Samples were then frozen on dry 
ice and transported frozen to the laboratory. Samples were transferred to a freezer and 
stored at -80° C.  
Nasal swabs were collected by inserting a sterile 14 cm culture swab, into the 
nasal cavity until resistance was met and then rotating against the nasal mucosa. Swabs 
were collected from the right and left nasal cavity and the two swabs from one animal 
were combined/pooled as follows. Using non-sterile medical gloves, the two swab tips 
were cut off and both together were placed in a single 1.5 mL micro centrifuge tube 
containing 500 μl PBS, and frozen on dry ice and transported to the laboratory where 
they were stored at -80° C. 
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  On arrival at the Oklahoma State feedlot, cattle were processed in the first 18 
hours of arrival. Samples for blood and nasal swabs were collected in the same manner as 
previously described. Calves were then given their second treatment on arrival. Calves in 
the PMEL and CON treatment groups received a placebo bolus. The remaining calves in 
the AMEL group received meloxicam boluses. The calves with in the three treatments 
were randomized and sorted to pens (n=18).  PMEL, AMEL, and CON were allotted to 
an equal number of pens (n=6). Pens were identical in nature and each calf was receiving 
identical rations. Specific pens shared waterers with no treatment indication that required 
separation of groups from water sources. Pens consisted of only one of the three 
treatments. On day 42 calves were weighed for performance purposes. Study animals 
remained in their respective pens throughout the feeding period until their specified 
harvest date on April 7, 2017. 
Processing 
The morning of on arrival processing, all calves received commercially available 
vaccines against bovine herpes virus -1, BVDV (types 1 and 2), parainfluenza virus three, 
bovine respiratory syncytial virus in a 5-way vaccine and clostridal pathogens in a 7-
wayc. All calves were administered a growth promoting implant containing 80 mg 
trenbolone acetate and 16 mg estradiol.d The anti-parasitic protocol required an oral 
drenche and injectable wormer.f Later in the feeding period, all steers on trial also 
received a second implant of 4 mg of estradiol and 20 mg of trenbolone acetateg on day 
70.  
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Feeding management 
Pens were an open dirt yard that measured 12.2m X 30.5m with the bunk lining 12.2 m of 
the pen. Feeding occurred twice daily throughout the feeding period at set times. Rations 
were formulated to meet or exceed the nutritional requirements of each calf.  Water was 
made available in each pen ad libitum. 
Bovine respiratory disease assessment 
Criteria for identifying cattle with clinical signs of BRD was designated to individuals 
who were blinded to treatment, trained to detect BRD, and were consistently available to 
monitor calves. A severity scoring system was used to rank animals that were deemed 
clinical for BRD. The scale of the score was on a 1 to 4 and was attributed as follows: 1-
mild, 2-moderate, 3 severe and 4- moribund. The scale of the score was based off of 
subjective clinical signs each trained individual was adept at identifying. Specifically, 
those signs included: animals that were off feed, gaunt in appearance, signs of dyspnea 
consisting of open mouth breathing with extension of the head and neck, hanging of the 
head in a depressed manner or a glassy appearance in the eye. If a severity score was 
assigned to an animal, it was removed from the pen for further evaluation. Most 
importantly the evaluation of interest was rectal temperature. The temperature criteria for 
treatment was set at 40∘C when a severity score reached severe. After the treatment 
decision was made, calves were returned to their home pen for further observation. A 
mandatory post treatment interval was assigned based on antibiotic treatment. 
Antimicrobials chosen were on label products for the treatment of BRD and given at the 
label recommended dose. Therapeutic regimen was the same for every animal that was 
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pulled and met the treatment criterion. A maximum of three antibiotic treatments were 
used per calf before they were deemed a treatment failure. Each antibiotic had an 
observed post-treatment interval that required observance prior to any further therapeutic 
intervention. First treatment was tilmicosinh at 1.5 mL/100 lbs BW, second treatments 
was florfenicoli at 6.0 mL/ 100 lbs. BW, and the third treatment was ceftiofurj 1.5 mL/ 
100 lbs. BW for 1st, 2nd and, 3rd BRD treatments. All antibiotics were administered SQ in 
the neck with the exception of exceed being administered SQ into the base of the ear. All 
dosing instructions followed the product label.  
Performance at harvest 
During the finishing phase cattle performance management, and carcass characteristics 
were performed in a manner consistent with previous publication 12. Cattle that are 
colored (primarily non-black hided) were sent to Dodge City, KS commercial facility 434 
km from the research station to be harvested. All black hided cattle were harvested in 
Arkansas City, Kansas 109.76 km in distance from the research facility. Oklahoma State 
University personnel qualified and standardized in quantifying carcass characteristics. 
Data generated in plant included: hot carcass weight (HCW), Ribeye area, marbling 
score, fat over the 12th rib, yield grade (YG), and quality grade (QG).  
Cortisol Analysis  
Circulating plasma was analyzed for cortisol and numerated via radio-immunoassay 
using a commercially available kit. Guided by the instructions provided by the 
manufacturer the quantifiable range of the assay was from 2.5 ng up to 300 ng / mL. The 
average standard curve (R2) is 99.8.  Validity of the assays for each run was confirmed 
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with internal standards at 10 and 100 ng / mL.  The coefficients of inter-assay and intra-
assay variability were at < 8 % and < 12.5 % respectively.  
Substance P Analysis 
Substance P concentrations were determined prior to shipment and on arrival.  In each 
EDTA blood tube, 200µg benzamidine was added 48 hours prior to the start of the study 
for protease inhibition.  Whole blood extracted from the jugular vein was inverted 3 times 
to guarantee homogenization with the protease inhibitor and EDTA.  The samples were 
centrifuged, frozen and stored as described previously in the design section.  Time frame 
of processing was 30 minutes for all samples.  
                 Substance P levels were determined using previously published methods 
described by using non-extracted plasma. 9  Detection ranged for the assay was between 5 
and 320 pg/mL. The coefficient if of variation for the intra-assay variability was 9.26% 
and the inter-assay variability was calculated to be 18.28%.  The average R2 for the 
calibration curve was 0.986.   
Annexin A1 Analysis 
Nasal swabs were passed into the nostrils of cattle as described previously in the study 
design portion of the materials and methods. A random subset of calves (PMEL=14, 
AMEL=19, CONT=18) were analyzed. The supernatant was collected and then frozen at 
-80˚C. Annexin A1 levels were measured and concentrated similarly to a previously 
described manuscript 13, with modifications as follows. Samples were concentrated by 
centrifugal filtration with a 3 kDa molecular weight-limit device,l purified,m and protein 
concentrations were measured.n Two fluid samples with intermediate concentrations of 
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annexin A1 were used as standards; these were used on each gel to facilitate comparison 
of test samples between gels and blots. Samples containing 10 g of protein were loaded 
on sodium dodecyl sulfate polyacrylamide gelso and separated at 200 V for 1 hour, then 
proteins were visualizedp and total protein in each lane was quantified by densitometry.q 
Proteins were transferred to a membraner that was used for western analysis. The 
membrane was blocked with 5% BSA for 1 hour, then incubated with rabbit anti-human 
annexin A1 antibodys overnight at 4oC, washed, and incubated with peroxidase-
conjugated goat anti-rabbit immunoglobulin as secondary antibody,t for 30 minutes, 
washed for 1 hour, and visualized by chemiluminescence.u  Bands (37 kDa), 
corresponding to that previously shown for annexin A1 13 were quantified by 
densitometry.q Data are shown as the density of the band on the western blot adjusted for 
the background density of the blot, normalized to the corresponding adjusted total protein 
value obtained by densitometric analysis of the sodium dodecyl sulfate polyacrylamide 
gels -PAGE gel. Quantitative data were confirmed by visual inspection of the blots and 
gels.   
Haptoglobin- Matrix Metalloproteinase -9 Analysis 
The Hp-MMP 9 ELISA was performed as described 14,15. The capture antibody was a 
monoclonal anti-bovine MMP 9 (clone 10.1; native bovine neutrophil MMP 9 antigen) 
and wells were blocked by the addition of 300 μL of SuperBlock T20v.  All plates were 
prepared at the same time to minimize variation between plates.   
The serum used as a standard was prepared from an ill bovine that previously had 
a verified Hp-MMP 9 of 913 ng/mL in a prior manuscript 14.  This previous aliquoted 
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standard was thawed on ice and sonicated for three consecutive one minute intervals, 
vortexed and serially diluted to create a standard curve as follows: 228, 114, 57, 28, 14, 7, 
and 3.5 ng/mL.  Blank wells contained all reagents, with serum from a healthy steer, 
diluted 1:10 in TBS+Tween 20.  Affinity chromatography and Hp-MMP 9 ELISA of this 
animal's serum demonstrated it was free of demonstrable Hp-MMP 9 (Lakritz J, 
unpublished observations).   
Serum samples from experimental animals were diluted 1:10 with Tris-buffered 
saline (pH 7.5) to which 0.05% Tween-20 was addedw prior to analysis by ELISA. 
Diluted standards and serum samples from experimental animals (100 μL) were placed 
into wells of a 96 well plate in duplicate (16 standards, 40 serum samples/plate) for 2 
hours on a plate shaker at room temperature.  After washing pre-diluted rabbit-anti-
bovine Haptoglobin-HRP conjugatex, were allowed to bind to haptoglobin that is bound 
to MMP 9 in the wells on a plate shaker for 1 hour.  After washing wells 5 times in Tris-
buffered saline (pH 7.5) with 0.05% Tween-20w, 100 μL of TMB substratey was 
added/well and color development was allowed for 20 minutes.  After 20 minutes, 100 
μL 0.1 N hydrochloric acid was added/well to stop the enzymatic reaction.  Standard and 
sample absorbance was determined on a micro-plate reader at 450 nM.  All samples 
whose absorbance at 450 nm or greater than the highest standard were re-diluted to 1:50 
with the Tris-buffered saline (pH 7.5) to which 0.05% Tween-20 was added diluent and 
re-assayed (56 samples total). Sample concentrations were determined by linear 
regression of the known standard concentration versus absorbance value, using the 
intercept and slope calculated from the linear regression and corrected for the dilution of 
the sample (10-fold or 50 fold).14  
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Statistical Analysis  
Analysis was performed using statistical softwarez. Experiment setup was 
analyzed as a randomized complete block design and the fixed effects of the model were 
treatments PMEL, AMEL, and CONT for all data investigation. BW was defined by four 
groups and also used as fixed effects.  Group one was weights less than 233 kg, group 
two was defined by BW between 234 kg – 239 kg, group three was defined by 250 kg -
266 kg and lastly group four was any BW greater than 267 kg. These fixed effects were 
categorical in nature and associations between treatment and BW at arrival with-in pen 
BRD morbidity, severity score, were tested using a generalized linear mixed model fitted 
as a binomial distribution. Severity score was assessed as ordinal ranging as follows: 0= 
normal, 1=mild, 2=moderate, 3=severe and moribund. These were fitted with a 
multinomial distribution, cumulative logit link and restricted pseudo-likelihood.  
Treatment and BW associations were accounted for at arrival and investigated as 
the fixed effects for the remaining outcomes of interest. Performance and carcass 
outcomes of ADG, DMI, HCW, REA, G:F, marbling, dressing percent were tested using 
linear mixed models with a Gaussian distribution, identity link, and residual pseudo-
likelihood. These data were continuous in nature. Random effects of interest for the study 
were pen, arrival date, and harvest site for the carcass outcomes. Random intercepts for 
pen and arrival pen were fitted as well as an unstructured covariance structure for 
animals, to account for the hierarchical structure of the data which consists of repeated 
measures of cattle over time, cattle nested within pens, and pens nested within arrival 
date. 
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Continuous values for cortisol, substance P, HP-MMP 9 complexes, nasal swab 
total proteins and annexin A1 required natural logarithmic transformation to meet the 
normality and homoscedasticity of the residuals. Generalized linear mixed model models 
were fitted including main effects for treatment and study day and a two-way interaction 
between treatment and study day, using a Gaussian distribution, identity link and residual 
pseudolikelihood estimation. Random effects for pen and arrival date were included. 
Initially, all models were fitted using a Laplace likelihood approximation technique in 
order to quantify overdispersion (Pearson χ2/df). Final models, when feasible, were fitted 
using a residual pseudo-likelihood approximation procedure. Akaike and Bayesian 
Information criteria were used to compare model fit. Model assumptions were tested in 
all models and residuals were investigated using graphical tools.  The Tukey-Kramer 
multiplicity correction was used for prevention of multiple treatment group comparison 
Type I error.  95% confidence intervals for means were calculated. Significance was 
indicated by P values less than or equal to 0.05 and statistical trends are indicated by P 
values between 0.05 and 0.10.  
Results 
Eleven animals were taken off trial. Five of the original enrollment claves died of 
heat stress before pen assignment. In the first week two succumbed to joint infections. 
Three months later one more study subject died of joint infection. The remaining three 
where removed late in the feeding period due to laminitis, lameness and respiratory 
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issues. No mortality was evident in the group as a consequence of acute BRD. This is 
depicted as percent mortality in table one and mortality was not analyzed statistically.  
The mean total respiratory morbidity treatment average of all trial pens was 
26.26%. Within the pens, morbidity ranged from 0% to 63%. Evaluation of the average 
first treatment respiratory morbidity percentage between PMEL, AMEL, and CONT was 
as 20.22%, 21.02%, and 23.08% respectively. These values had no statistical differences 
between them (P=0.8674).  Of note, all pens that experienced 0% morbidity (n = 3) were 
assigned to meloxicam treatment. Further evaluation of first treatment in morbidity over 
days one through ten and days one through thirty are depicted in table 1. The number of 
total days in the yard until first treatment for BRD was needed, relative to day 0, was 
termed day of treatment. This time to first treatment in days did not differ between groups 
(P= 0.7092). The severity of sickness for calves pulled to be treated in the feed yard was 
assessed. These severity scores of the different groups were not different (P = 0.6342). In 
addition to assessing the subjective severity of sickness, rectal temperature was also taken 
for animals that were pulled. No differences in rectal temperature between the groups 
AMEL, PMEL, and CONT were seen in the calves identified during clinical evaluation 
(P=0.7863).  
Evaluation of live performance data occurred over the first 42 days of the trial 
(Table 2) and again at the final day of the feeding period. Weights between treatment 
groups did not differ on individual day comparisons prior to transportation, on arrival or 
at day 42 of the study period (P > 0.10). For all groups, there was no significant 
difference in weight between day -1 and day 0. There was an increase in BW over time 
from day 0 to day 42 (P = 0.0001). Similar to this finding further comparisons 
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highlighted significant differences between day 0 and day 42 from the final BW (P ≤ 
0.001).  The with a ADG, in kg per day, from day 0 to day 42 for AMEL, PMEL, and 
CONT were 1.80, 1.75 and 1.77 respectively with a standard error of 0.07. These values 
did not differ statistically between treatment groups (P = 0.5615). Despite the overall lack 
of differences between the treatment groups for most variables, a treatment effect was 
detected between AMEL and the CONT groups for DMI (P = 0.011).  Within the model, 
BW was split into 4 categorical variables as previously stated in the statistical analysis 
section. BW was also had a significant ( P < 0.0001) on DMI and there was an interaction 
between treatment and the BW effects ( P < 0.0006). As each BW category increased 
from 1 to 4 there as an increase in the DMI for each group. 
 Harvest performance parameters for all three treatments (PMEL, AMEL, and 
CONT) are reported in Table 3.  The total number of days in the feed yard did not differ 
between pens and treatment groups. This was not analyzed statistically and the average 
for all was 235 days on feed. The end BW comparison between PMEL, AMEL and 
CONT were similar (P = 0.6332) and incorporated into calculation of ADG over the 
entire feeding period.  Using initial BW of each group on arrival (P = 0.7381), there was 
no significant difference of ADG over the entire feeding period (P = 0.3480). Data 
pertaining to carcass characteristic parameters, HCW, HCW/final BW, ribeye area, fat 
over the 12th rib, QG, YG, and marbling score, were recorded at the harvest facilities. The 
HCW was very similar between groups and there was not differences that were observed 
through statistical models (P= 0.8587). When accounting for BW on arrival at day 0 in 
the model there was significant effect (P= 0.0009). Significance differences were 
between weight group 4 from 1 and 2.  In line with the lack of treatment difference for 
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the HCW and the final BW, the dressing percentage was also similar between groups (P 
= 0.5854).  Changes in the marbling score and the measured fat over the 12th rib were 
also unaffected by specific treatments at arrival. P values for these respective parameters 
were 0.6531 and 0.5792. Ribeye area and the YG of the carcass also remained unchanged 
between PMEL, AMEL, and CONT (P > 0.10).  
Circulating biomarker means are presented in Table 4. All biomarkers were 
natural log transformed for statistical analysis and then back transformed for 
interpretation in table 4.  Cortisol levels in circulating plasma did not differ over time (P 
= 0.5194) or by treatment (P = 0.7839) and there was no interaction between time and 
treatment (P=0.6973).  Substance P concentrations increased over time from day -1 to 
day 0 (P< 0.0001) with no treatment effect (P = 0.1474).  The interaction between time 
and treatment was not significant (P=0.9076).  In circulation, Hp-MMP-9 increased over 
time (P= 0.0015) however there was no difference due to treatment (P= 0.7563). The 
interaction between time and treatment was not significant (P=0.2879).  
Total protein in swabs of the nasal cavity were significantly increased on arrival 
(P=<0.001) and there was no treatment effect (P=0.7440). The interaction between time 
and treatment was not significant (P=0.7669).  Annexin A1 concentration per mg of 
protein were significantly decreased on arrival (P=0.0004) and there was no treatment 
effect (P= 0.2603). The interaction between time and treatment was not significant 
(P=0.3160). When accounting for total protein in annexin A1 and viewing annexin levels 
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as mg per mL of nasal secretion, there is no significant change from over time (P = 
0.8472) or by treatment (P = 0.8472). 
Discussion 
The utility of a prophylactic therapeutic, meloxicam, is to benefit the health of the 
animal through reduction of pain and stress during or after transport. With current 
approved drugs on the market in cattle, no approved therapeutic is labeled for pain or 
stress relief.  For cattle, meloxicam has become an intensively investigated extra label 
drug use NSAID. As described in previous literature, there are benefits during surgical 
procedures to prevent disease16 and reduction of pain in common procedures of bovine 
production medicine.17-19 Meloxicam is a member of the oxicam drug class and 
preferentially inhibits cyclooxygenase II activity, which has a physiologic role in 
prostaglandin production.20 Oral administration of meloxicam is pharmacokinetically 
proven to have high bioavailability and a half-life of 26 hours in the ruminating bovine.21  
These properties of the drug are advantageous when administering a dose prior to or after 
transport as well as during other production practices. Recent work indicates that 
meloxicam dosed prior to transport has benefit in reducing the stress response associated 
with transport9 and decreasing the acute phase protein response while preventing 
performance losses on arrival.8  
With a non-integrated beef system, economic, geographic and spatial limitations 
of feed yard infrastructure results in long distance transportation for most calves.22 This 
necessity for cattle shipment is an additional factor for increased likelihood of BRD as 
well as other contributing factors such as colostrum management at birth,23 weaning 
stress24 and comingling.25 In the present study, we were able to account for and locate 
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calves that were comingled from multiple sources and transported over a long distance. 
Due to the origination of lightweight calves from a sale barn, we suspected that the 
weaning management was minimal. The environment was ideal for the transmission of 
respiratory pathogens from infected to naïve animals with additional stressor events to 
decrease the innate and adaptive immune response to BRD.2,26  When purchased, these 
calves were deemed high risk, however they did not encounter the same pattern of high 
morbidity that we would have anticipated. Calves identified as high risk can have group 
morbidity reach upwards of 65-80% of the incoming comingled herd.27  Our incoming 
cohort only experienced a total number of treatments ranging from 23.08 % to 29.03 % 
with a SEM of 7%. However, there is still a potential benefit despite the lack of statistical 
significance when investigating NSAID therapy as a sole option for preventative 
mitigation of BRD.  
Past literature has described the benefit of administering NSAIDs during the advent of a 
painful or stressful stimulus to alleviate acute stress responses.9 In a field study, 
meloxicam used as a standalone treatment for BRD resulted in greater weight gain over 
the feeding period and a decrease in lung lesions at slaughter when compared to control 
animals.28 Additionally, the kinetics of meloxicam allows a singular administration to 
provide three days of therapeutic benefit in comparison to three consecutive days of 
flunixin meglumine treatment.29  Meloxicam provides added benefits for receiving 
performance.8 Presumably this additional performance on arrival is attributed to pain and 
stress relief. Due to these literature findings, we hypothesized that meloxicam 
administration, either prior to transport or on arrival, would decrease the severity of BRD 
morbidity for incoming high-risk calves through the reduction of pain, stress and added 
151  
 
performance.  This trial allowed us to reject this hypothesis. There was no difference 
between animals that receive the NSAID before or after transportation on the incoming 
first treatment for BRD. When treatments are isolated to the first 10 days, there is also no 
difference. Additionally, those animals that do become clinical do not have any reduction 
of temperature when treated with meloxicam prior to shipment or on arrival. Severity 
score was similar between the PMEL AMEL and CONT groups. Most of the respiratory 
disease encountered with in the feed yard was mild to moderate in severity. A study 
cohort with more moderate defined sickness was desired.  Descriptions of an induced 
BRD model lack an effect of NSAID treatment on behavior as well as clinical signs.30   
Differences of severity in BRD were one of the suggested means of masking of potential 
positive or negative effects.30  As authors, we would not advise the use of meloxicam as a 
pre transport or on arrival standalone management practice for BRD and would suggest 
the combination with and antibiotic approved for use against BRD.  
Meloxicam falls under the animal medicinal drug use clarification act of 1994 as 
extra label drug use. However, it is of importance to stress that the sole justifiable use of 
meloxicam for production purposes is not warranted. In addition, these drugs may not be 
used in feed and a violation residue is prohibited. We hypothesized that the use of 
meloxicam to reduce pain and stress prior to transport or on arrival would have beneficial 
effects on ADG, DMI and G:F at 42 days. Justification for this hypothesis originated 
from previous research suggesting dairy calves treated with meloxicam, prior to the stress 
of dehorning, spent more time standing at the feed bunk and gained better.19,31 Over the 
study period, all three groups gained significant weight during the first 42 days. There 
was no added treatment benefit for ADG or G:F between day 0 and 42.  Previous authors 
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have indicated a meloxicam effect for decreasing the shrink associated losses in the first 
week and additional benefits for increased ADG and G:F over the 21 days after arrival 
when comparing meloxicam treated groups to the transport controls. 8 We would agree 
with these authors’ results for the first 21 days, but they did report data beyond the 
designated 21 days. The focus of this trial was a singular 42 d data collection.  The results 
indicate that compensatory gain negates the potential original performance benefit. DMI 
had a significant interaction between weight and treatment. Likely this interaction does 
not translate to a substantial effect of treatment but rather is more a function of the weight 
at arrival. This is supported by a lack of difference in the measured parameters connected 
to DMI; ADG and G: F. Flunixin meglumine, another NSAID labeled for pyrexia in 
cattle, has also been investigated at cattle receiving after long distance transportation. 
This therapeutic option did not improve any receiving performance of the feeder cattle 
over 28 days.11   This is not surprising considering events such as castration can decrease 
the ADG and G:F with in the first 14 days  however detecting effects at day 28 is not 
possible.16 
Carcass performance in feedlot cattle is influenced with on arrival decision 
making. These initial processing decisions, such as metaphylaxis32 or vaccination33 can 
make a difference at harvest. Disease related inflammation can have negative effects on 
harvest through partitioning of energy sources to catabolic processes associated with 
immune function and the acute phase proteins.34 The most notable partition of 
immunologic energy in the feed yard is accounted for in the combat of BRD. We 
hypothesized that the decrease in inflammation through use of a NSAID would be 
beneficial in reducing subclinical inflammation associated with transport and aid in 
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partitioning of energy to enhance carcass outcomes. When evaluating all of the carcass 
data we reject our hypothesis; NSAID treatment on arrival or prior to transport does not 
influence the majority of carcass performance. Other investigators have described a lack 
of benefit on carcass characteristics when using NSAID as ancillary therapy to BRD 
treatment in feedlot cattle.35 There may be a difference in outcome based on the time of 
administration prophylactically versus at diagnosis. Benefits at harvest can lead to 
premiums if cattle are marketed appropriately on grid pricing.36  Benefits of a singular 
oral meloxicam dose during a time of inflammation have improved performance in other 
production practices, most notably increased lactation in the dairy cow.37  In addition the 
hypothesis of an increased performance at arrival as described by Guarnieri et al., could 
potentiate the lingering benefits if the project were performed in a different cohort. 
However, we acknowledge the lack of investigation with in the 7 and 21 days due to 
constraints of the study design and personnel.   
Addressing biomarkers prior to and after transportation scenarios has been done 
extensively. In this manuscript we choose biomarkers based on indication for stress,38 
pain,39and correlation to BRD.13,14  
Cortisol is a commonly investigated glucocorticoid hormone that is used as an 
indicator of stress during and after transportation.40  Previous investigation confirmed that 
the cortisol release was inversely proportional to meloxicam concentrations and was 
critical in reduction of the stress leukogram.9 We hypothesized that treatment with 
meloxicam would again have a reduction of  cortisol and there would be a correlation of 
the reduction. We however reject this hypothesis for calves in this trial. Cortisol 
confounding by natural circadian rhythm41 and differences in the types and breeds can be 
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attributed.  Despite the lack of observed changes in cortisol over time and the lack of a 
treatment outcome we would not attribute this to a lack of stress during transport. 
Subjectively and non-statistically interpreting the cortisol levels, CONT animals did have 
a higher cortisol on arrival (40.17 ± 1.10 ng/mL) when compared to PMEL treated 
animals (35.22 ± 1.10 ng/mL ) and AMEL animals (37.91 ± 1.10). Indication of the 
singular sampling time points as the potential confounder along with study subjects 
should be taken into consideration.  
Substance P is a neurotransmitter stored in the dorsal horn of the spinal cord and 
released in response to cutaneous noxious stimuli.39  In calves, plasma concentrations of 
substance P have been considered a potential biomarker of pain following castration.42  
Circulating increases have also been inversely proportional to meloxicam concentrations 
after scoop dehorning.19  Suggesting an analgesic benefit of NSAID therapeutics. 
Transportation has been described to increase the circulating neuropeptide.9 We 
hypothesized an increased substance P at arrival. The present study’s cohorts had an 
increase in substance P over time confirming our hypothesis. This agrees with the 
previous trials.9 We also hypothesized a decrease in substance P for animals in the PMEL 
group when compared to AMEL and CONT. We rejected this hypothesis. No treatment 
effects were noted. When comparing circulating substance P levels, the concentrations of 
substance P in our study is drastically less than those involving incisional castration 
(506.43 ± 38.11) and even drastically less than uncastrated controls (386.42 ± 40.09 
pg/mL) .42  Despite the differences in analysis method and the ability to draw conclusion 
through comparison out right, the percent change of these two studies is also markedly 
different than ours. Potentially, there is less efficacy for meloxicam in a scenario that 
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does not have a parameter of incisional damage for a pain response. Interpretation of the 
neuropeptide in a transport scenario as a marker of pain is still warranted from an animal 
welfare standpoint. Some literature supports the hypothesis that there is more likely a 
stress response with transport rather than a pain response24 however a combination of the 
two is still highly plausible based on cattle handling, disposition, and transport methods.  
HP- MMP-9 complexes released in response to acute inflammation are useful 
diagnostically at identifying pulmonary inflammation; as described in a previous 
challenge model.43  Haptoglobin has been investigated in transport studies as part of the 
acute phase protein response during weaning and transport of cattle.25,44 However, the 
best indicator of inflammation is a complex of HP-MMP-9 in comparison to either HP or 
MMP-9 individually.14  With an indicator of inflammation associated with disease, we 
hypothesized that there would be an increase of HP MMP-9 over time and a decrease in 
the HP-MMP-9 levels for animals treated with meloxicam. We were correct in our 
hypothesized statement and a significant increase over time for circulating HP-MMP-9 
occurred. However, there was no effect of meloxicam to reduce the biomarker in 
circulation. This is consistent with previous work.9 Though HP-MMP-9 has been 
validated as a marker of pulmonary inflammation, using haptoglobin alone as early 
indication of BRD on arrival has limited utility in deciding BRD treatment methods.12 In 
this trial, due to past results of meloxicam’s minimal effect these results were not 
surprising, but necessary to identify responses of different animal cohorts to relay the 
universal nature of the change in beef cattle after transportation. Reasons for lack of 
identifying BRD may have been constrained by the lower percentage of BRD compared 
to Holland et al.’s investigation of haptoglobin as a predictor and our lack of high 
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severity scores. Using this marker would still have utility but timing and degree of illness 
are likely crucial.  
Annexin A1 are proteins conserved heavily throughout the animal kingdom and 
are functionally, on a molecular level, membrane stabilizers. 45 In cattle, stress induction 
drastically increases annexin A1 in bronchial alveolar lavage fluid. 46  Release of annexin 
A1 has been associated with a reduction in pro-inflammatory effects through 
phospholipase A2 and cyclooxygenase II inhibition. 
47 Increases in levels of annexin A1 
have also been described as indicators of resistance to respiratory disease. 3 Due to the 
high correlation of annexin A1 to glucocorticoids Senthilkumaran et al. suggested a 
complex relationship between stress glucocorticoids annexin A1 and susceptibility to 
pneumonia.3 From this, we hypothesized an increase in annexin A1 levels on arrival and 
a treatment effect decreasing the levels of annexin A1. We rejected this hypothesis and 
instead saw a decrease in the number of annexin A1 proteins with in the nasal swab 
sample. However, this was confounded by the rise in total protein in the nasal swab and 
skewed the identification of annexin A1. The annexin A1 was originally reported as 
annexin A1 per mg of protein. When accounted for and annexin was viewed 
independently per mL of nasal fluid, there was no difference between groups. To account 
for this, we multiplied the μg of annexin per mg of total protein the mg total protein per 
mL of nasal fluid extract to result in μg annexin per mL nasal fluid extract. This lack of 
change may have been due to the high levels already present when initial sampling began 
on day -1. Alternatively, no changes in cortisol between both sampling timepoints may 
also be involved. The lack of other sampling days to prevent BRD assessment 
confounding and the small subset of samples may have attributed to a lack of meaningful 
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treatment findings. Total protein in the nasal swab was significantly increased on arrival 
compared to pre-transit samples. This was suspected due to previous reports of increased 
proteinaceous nasal secretions after stress and inflammation. Similar to assumptions with 
HP-MMP9, annexin A1 as a marker has utility but reiteration of timing and degree of 
illness is important.  
In conclusion, meloxicam administered prior to transportation or on arrival has no 
influence on the number of BRD cases. Incoming calves that do develop clinical BRD do 
not differ in time to treatment and rectal temperature compared to untreated controls.  
Additionally, there was no effect on ADG or G:F at 42 days on feed. ADG at the final 
day of the feeding period and carcass characteristics are undistinguishable between 
groups. Circulating biomarkers are affected by the event of transportation. These trends 
signify inflammation and align with previous publications and research. No treatment 
effects on transportation biomarkers were noted. The lack of significance could be 
limited by sampling timepoints. However, the few sampling timepoints were constraints 
of budget, personnel, and intentional to limit disruption of days monitoring for disease. 
Meloxicam is still a valuable option as an ancillary treatment and would be beneficial in 
tandem with antibiotic therapeutics.  
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a Meloxicam Tablets, 15mg per tablet, USP; Aurobindo Pharma USA, Dayton, NJ 
b Titanium 5; Elanco Animal Health, Greenfield, IN 
c Vision 7; Merck Animal Health, Madison, NJ 
d Component TE-IS implant; Elanco Animal Health, Greenfield, IN 
e Safeguard; Merck Animal Health, Madison, NJ 
f Dectomax; Zoetis Animal Health, Florham Park, NJ 
g Revalor XS; Merck Animal Health, Madison, NJ 
h Micotil; Elanco, Greenfield, IN 
i Nuflor; Merck, Summit, NJ 
j Excede; Zoetis, Florham Park, NJ 
k Corti-cote [125 - I] Radioimmunoassay Kit: MP Biomedical, Eschwege, Germany 
l Amicon Ultra-15, Millipore, Billerica, MA, USA 
m Ready Prep 2-D Cleanup Kit; Bio-Rad Laboratories, Hercules, CA, USA 
n Nanodrop 2000C, Thermo Scientific, Rockford, IL, USA 
o TGX Stain-Free Fast Cast Acrylamide solutions, BioRad, USA 
p ChemiDoc, BioRad, Mississauga, ON, Canada 
q Image Lab software, Bio-Rad, Laboratories, Hercules, USA 
r TransBlot Turbo PVDF Membrane, BioRad, Mississauga, ON, Canada 
s 1:375; H00000301-D01P, Novus Biologicals, Oakville, ON, Canada 
t 1:3000; DakoCytomation, Glostrup, Denmark 
u Clairity ECL western blotting substrate, BioRad, Mississauga, ON, Canada 
v Thermo Scientific, Pierce, Rockford, IL, USA 
w Tris-buffered saline (TBS) 1X Cold Spring Harbor Protocols, 2009; doi:10.1101/pdb.rec11830 
x Immunology Consultants Laboratory, Portland, OR, USA RHPT-10A; 1:5,000 dilution 
y Kirkegaard & Perry Laboratories, Gaithersburg, MD, USA; 50-76-11 
z SAS 9.4, SAS Institute Inc., Cary, North Carolina 
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Table 1.  Mean values for total number of animals requiring treatment for BRD, breakdown of the percentages of first 
treatment and those treat with in the first 30 days, severity score, rectal temperature and average day of treatment for pulls.  
 
 
 
 
        
 
  
 Variable  AMEL (n= 6 pens) PMEL (n= 6 pens) CONT (n=6 pens) SEM P-value
§  
  Total Mortality (%) 1.70 3.50 1.10 ― ―  
  Total Morbidity (%)† 24.53 29.03 25.13 7.00 0.8033  
  First treatment morbidity (%) 21.02 20.22 23.08 6.95 0.9579  
    Day 1-10 (%) 15.09 16.13 17.30 ― ―  
    Day 1-30 (%) 16.98 20.96 19.23 ― ―  
   Day of treatment ¶ 8.27 10.63 16.39 7.05 0.7092  
   Severity score ‡ 1.75 1.25 1.72 0.41 0.6342  
   Rectal temperature (°C) 40.37 40.44 40.61 0.29 0.7863  
           
 
§Significance was defined at P≤ 0.05.†Total morbidity percent refers to the total number treated per group and includes 
those animals treated twice with in the first 100 days. ¶ Day of treatment refers to the mean day for animals pulled and 
treated. ‡ Severity score ranged from 1(mild), 2(moderate), 3(severe) to 4 (moribund). ― indicates that groups were not 
analyzed statistically 
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Table 2. Mean values of live performance variables at the pen level separated by allotted treatment 
 
           
 Variable Time (d)  AMEL  PMEL  CONT  SEM P-value
§  
 BW(kg)  -1  253.53 252.36 248.39 9.99 0.9302  
   0  254.76 251.29 245.33 8.57 0.7381  
   42  330.67 325.17 319.17 10.31 0.7368  
           
 ADG (kg/d)  0-42  1.80 1.75 1.77 0.07 0.8888  
 DMI (kg/d)  0-42  7.37
a 7.53 7.62b 0.05 0.011  
 
Ratio of ADG to DMI 
(G:F) 0-42  
0.2415 0.2338 0.2328 0.011 0.7957 
 
           
 
Treatment administration occurred prior to transport on day -1 and again on day 0 arrival processing.                                                                    
§Significance was defined at P≤ 0.05. letter differences indicate significance between groups. 
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Table 3.  Mean values for the total days in the feed yard, the initial and final BW, ADG, and carcass characteristics 
 
               
 Variable  AMEL   PMEL   CONT  P-value
§  
    mean  (±sem)  mean  (±sem)  mean  (±sem)    
               
 
Total days in the 
feedlot 235.00   ―  235.00   ―  235.00      ―  ―  
 Initial BW (kg)  254.76 (± 8.57)  251.29 (± 8.57)  245.33 (± 8.57)  0.7381  
 Final BW (kg)  662.33 (± 10.89)  656.71 (± 10.89)  640.66 (± 10.89)  0.6332  
 ADG (kg/d)  1.72 (± 0.03)  1.73 (± 0.03)  1.68 (± 0.03)  0.4223  
 HCW (kg)  393.95 (± 11.08)  397.59 (± 11.00)  396.02 (± 11.02)  0.8587  
 HCW/final BW (%)  60.70 (± 0.84)  61.71 (± 0.79)  61.83 (± 0.86)  0.5854  
 Ribeye area (cm
2)  84.19 (± 4.15)  79.63 (± 4.15)  76.90 (± 4.15)  0.3715  
 
Fat over 12th rib 
(cm)  1.35 (± 0.14)  1.40 (± 0.14)  1.30 (± 0.14)  0.5792  
 USDA QG  3.04 (± 0.05)  3.08 (± 0.05)  2.89 (± 0.05)  ―  
 USDA YG  3.19 (± 0.31)  3.44 (± 0.31)  3.25 (± 0.31)  0.3630  
 Marbling score  471.15 (± 23.59)  463.37 (± 23.23)  454.47 (± 23.84)  0.6531  
               
 
§Significance was defined at P≤ 0.05 and trends are indicated by P≤ 0.10. Quality grade was indicated by 
translating standard (1), select (2), Choice (3), and Prime (4) to numeric values and averaging. ― indicates that 
groups were not analyzed statistically 
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Table 4.  Back transformed mean values for biomarkers analyzed on days -1 and 0.  
 
     AMEL PMEL CONT P-value
§  
 Variable  
Time 
(d) mean  (±sem) mean  (±sem) mean  (±sem) 
Treatment Time Interaction 
 
 Biomarker          
  
 
  Annexin 
A1(ng/mL) 
- 1  10.90 (± 1.19) 11.68  (± 1.21) 12.08 (± 1.18) 
0.8525 0.0004 0.3192  
  0 8.72 (± 1.19) 7.35 (± 1.21) 6.29 (± 1.18)  
               
  Total Protein 
(ng/mL) 
-1 45.45 (± 8.05) 57.09 (±8.68) 49.04 (±7.88) 
0.3749 <.0001 0.838  
  0 64.44 (± 8.05) 82.52 (±8.68) 74.68 (±7.88)  
               
  Cortisol (ng/mL) 
-1 36.96 (± 1.10) 35.78  (± 1.09) 35.96 (± 1.10) 
0.7839 0.5194 0.6973  
  0 37.91 (± 1.10) 35.22  (± 1.09) 40.17 (± 1.10)  
               
  HP- MMP9 
-1 0.54 (± 0.35) 1.09 (± 0.33) 0.74 (± 0.35) 
0.7563 0.0015 0.2879  
  0 1.79 (± 0.35) 1.52 (± 0.33) 1.39 (± 0.35)  
               
  
Substance P 
(pg/mL) 
-1 
76. 
91  (±1.29) 78.54 (±1.29) 70.12 (±1.29) 0.1474 <.0001 0.984  
  0 87.28 (±1.29) 89.30 (±1.29) 80.55 (±1.29)  
               
 
§Significance was defined at P≤ 0.05.  Similar letters between groups indicate no significant differences between groups.  
Annexin A1 and Total Protein were determined form nasal swabs of calves at designated time points. Cortisol, Hp-MMP9 and 
Substance P were all quantified from blood samples.  
 
  
               
1
6
6
 
 
167  
 
 
CHAPTER 6.  
GENERAL CONCLUSIONS 
 The results of the research trial described in chapter 3 was successful at indicating 
a stress and inflammation response during long distance transportation for beef steers. 
This was identified as an increase in circulating cortisol, substance P, TNF α, Hp-MMP9 
complexes and hematologic changes indicative of a bovine stress leukogram. 
Administration of an oral meloxicam dose of 1 mg per kg with 15 mg tablets was able to 
reduce the hematologic stress leukogram response. The remainder of the dissertation 
focused on this targeted dose and route of administration.  The reduction in hematologic 
neutrophilia and monocytosis after shipping is suggestive of having a positive impact for 
the bovine after transportation. When meloxicam concentration levels were quantified in 
plasma, there was an inverse proportion of drug concentration to cortisol, neutrophils, 
and basophils. These results prove that meloxicam has benefit at reducing biomarkers of 
stress in cattle during transport.  
 This transport associated stress and inflammatory finding is consistent with a 
majority of the literature (Arthington et al., 2003, Browning and Leite-Browning, 2013, 
Buckham Sporer et al., 2008, Kang et al., 2017). When compared to other trials 
investigating NSAID therapeutic benefit in the midst of transport, similar results were 
concluded. Flunixin meglumine was also effective at reducing the cortisol response as 
well as inflammation; acute phase proteins (Cooke et al., 2013). Though this was 
accomplished, performance was not influenced by flunixin meglumine. Conversely, 
different investigators who also have interest in meloxicam during transportation 
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displayed a performance benefit with in the first week (Guarnieri et al., 2014).  Though 
there was evidence of potential positive benefits of NSAID use in the scenario of 
transportation to reduce the stress responses, immune function with NSAID 
administration and transportation were unclear. 
 In our second trial, we addressed the issue of immune function after transport and 
the effects of meloxicam. Calves were immunologically challenged on arrival with a 
commercially available MLV (Bovi-Shield Gold, Zoetis). Adaptive immune system was 
monitored on arrival and one week following the vaccination. This was accomplished 
through in-vitro stimulation of PBMC’s with BVDV antigen and MP-FCM analysis as 
describe previously by Platt et al., ( 2009). Transportation affected circulating PBMC’s 
on arrival and one week after an on-arrival vaccination. Humoral response to BVDV was 
increased after one week and there was no difference between groups. Meloxicam did not 
have an effect on CMI when calves were in the non-transport group. In most cases the 
responses of meloxicam treatment CMI were similar in expression of CD 25, IL 4 and 
IFN γ to the non-transport controls. One week after arrival and vaccination, CMI differed 
between the control transport group and the meloxicam treated transport group. 
Treatment mitigated the transportation-associated increase in CD 25 expression by 
PBMCs, CD4+, and γδ+ T cells. Though there was a difference in transported groups, the 
meloxicam treated transport group consistently did not differ from non-transported 
groups. As a function of meloxicam’s effect on PBMCs, we cannot determine the type of 
effect after the conclusion of the research trial. There are two viable options either in 
stressful situations meloxicam is inhibitory or maintains homeostatic function of the cells. 
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Regardless of direction, the best way to confirm this was through a field trial 
investigating disease outcomes.  
 This was the first research trial to investigate meloxicam’s effects on the adaptive 
immune system after a transportation event. Others support our findings that in a non-
stressful state, meloxicam does not have inhibitory effects on the immune system 
(Maslanka and Jaroszewski, 2013). Other proof of concept was validated in previous 
work proving that meloxicam as well as flunixin has no effect on cellular apoptosis in 
bovine T cells (Maslanka et al., 2010). The PGE2 production inhibits the CD 25 
expression on T cells (Maslanka et al., 2014) and also prevents IFN γ production in γδ T 
cells (Przybysz et al., 2016). This finding substantiates the idea that meloxicam would be 
homeostatic rather than inhibitory through the mechanism of action to inhibit COX II 
preferentially and decrease the enzyme’s production of prostaglandins. Taking the data 
from both chapters 3, 4 and previous research we inclined to assume that meloxicam is 
beneficial for specific stress and immune associated aspects of the bovine during 
transportation.  However, though these hypotheses were elucidated, we needed a method 
to substantiate a production translation and investigate a clinical outcome that could be 
drawn from meloxicam’s use in a stressful situation to combat disease. Focus of interest 
would be an alternate hypothesis that meloxicam would aid in prevention of the most 
common and costly clinical outcome of transportation; BRD.  
 Finally, we investigated the efficacy of meloxicam in a production setting to look 
at the potential effects of meloxicam on clinical outcomes. A randomized, blocked, 3 arm 
parallel study design with no crossover was implemented. To add a practical component 
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to the study design, the third arm of the study. On arrival meloxicam treatment was added 
as the third arm. Most veterinarians and producers have a difficult time accessing cattle 
prior to transportation. Because of this limitation, we felt the addition was justified in our 
research. With mitigation of the stress response and presumptive homeostatic effects on 
the immune system using an oxicam class NSAID, we hypothesized meloxicam would 
reduce the BRD associated morbidity and decrease DART outcomes. Execution of the 
project allowed us to reject our hypothesis. After evaluation of the clinical outcomes we 
had no changes in the morbidity between meloxicam treated groups and the control 
groups over the entire trial period. Of the cattle that were pulled for BRD sickness 
through the DART system, no differences were seen in the clinical outcomes measured in 
sick cattle. The performance in the first 42 days showed no difference in ADG or G: F. 
Most of parameters at harvest were not significantly different between groups. The ADG 
and final body weights were not different. The HCW, dressing percent, YG, marbling 
score, ribeye area, and fat over the 12th rib also remained unchanged between treatment 
groups. Lastly, of the biomarkers analyzed, no treatment effects were elucidated. 
Treatment with meloxicam pre-transport ended in a higher substance P on arrival. HP-
MMP-9 and Annexin A1 all had significant time effects. The only correlation to BRD 
was the population of calves with a lighter body weight were more prone to develop 
BRD. This was then included in the model as a fixed effect. This was the case without an 
effect of treatment. 
 Contradictory to our initial hypothesis, meloxicam did not benefit calves entering 
the feed yard in the aid to prevent clinical BRD. There was no benefit in the first 42 days 
of the feeding period. Other published research suggests meloxicam was beneficial as aid 
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in performance over the first week of the feeding period through gain and feed efficiency 
(Guarnieri et al., 2014). Administering a therapeutic for performance benefits is not a 
justifiable use for ELDU, however this unintentional beneficial consequence through the 
true targeted action of stress or pain reduction would justify use. Any benefits of 
performance and increased feed efficiency were hypothesized to be related to the stress 
reduction as mentioned in the chapter 3 summary. These benefits were not seen in our 
study, most likely due to compensatory gain.  Monitoring for performance benefits at 42 
days on feed consisted of ADG, DMI, and G:F. Others have reported greater carcass 
weights at harvest and reduced lung lesions when meloxicam was administered at BRD 
onset (Friton et al., 2005). Findings related to health were similar to all other findings in 
the trial. No evidence of reduction in 1st pulls or overall treatments. This was different 
from Friton et al., whom instead treated cattle with the NSAID at BRD diagnosis. Lastly 
the biomarkers from circulating plasma and nasal swabs were not influenced by 
treatment. Others have correlated increased annexins to BRD resistance (Senthilkumaran 
et al., 2013), and HP-MMP9 to inflammation associated with BRD (Bannikov et al., 
2011). Cortisol has been measured to account for indication of stressors (Arthington et 
al., 2003) and substance P have also been measured to account for pain (Coetzee et al., 
2008).  The increases noted in the trial were in line with our hypothesis. The lack of 
treatment significance allowed us to reject the hypothesis of a treatment benefit to reduce 
these biomarkers in populations at high risk for BRD. The fifth chapter for sampling 
timepoints were insufficient and constrained. The primary study design objective to 
monitor for BRD without confounding days with data collection or stressor events. 
Lining up timepoints and cortisol levels to substantiate the same evidence can be 
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difficult. With that said, there is justification for meloxicam use regardless of the lack of 
significant findings on these biomarkers in chapter 5. Changes may have occurred but 
were missed. Simple indicators such as bodyweight, distance traveled, shrink, and 
origination are still the best for the practicing veterinarian when deciding risk category. 
Previous researchers have accounted for the these results; bodyweight, shrink, and 
distance traveled have a high impact on BRD outcomes in the feed yard (Cernicchiaro et 
al., 2012).  
 The dissertation research confirms that meloxicam is beneficial when 
administered prior to transportation for reduction of the stress leukogram and potential 
normalization of immune function but lacks clinical efficacy in mitigation of disease 
outcomes or live animal performance. As the bovine industry moves forward it is critical 
to address the animal’s welfare and appeal to the public’s perception of industry 
practices. In this unavoidable life event, strategies to improve bovine welfare with the use 
of pharmaceutics is paramount. Meloxicam’s substantiated research as an analgesic as 
well as for stress reduction would still error on the side of a justifiable ELDU. Without 
expectation of dramatic financial gain from therapeutic use, the ability to persuade a 
producer into use would be difficult. Fortunately, generic meloxicam is affordable and 
does provide them anecdotal evidence to be beneficial. Non-reported data from a 
collaborative field trial with a veterinarian transporting Holstein bull calves from Texas 
to Iowa described treated animals as more bright, alert, and aggressive at the feed bunk. 
The producer was blinded to treatment. Antibiotic treatments for respiratory disease 
between the groups was not different in the first 45 days and weights were not different 
between a MEL and CONT treated groups. Data back revealed similar results to chapter 
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5. However with an n=90, the use of data for treatment was limited.  Moving forward, 
further investigation is required with other novel therapeutics as well as other classes of 
non-pharmaceutical products that enter the market. The targeted approach of the 
pharmaceutical industry should be at therapeutics to modulate and enhance the immune 
system or pharmacologic agents to reduce anxiety without repercussions of sedation. 
However, the greatest impact would be a full-scale change in the beef industry. This 
arduous task would take a great effort from multiple parties. Based on the findings of this 
doctoral project, the best guided approach at combating transportation stress start before 
transportation. In summary, great management practices would trump any pharmaceutical 
intervention.  
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